1
|
Saulnier A, Wendling JM, Hermant B, Lepelletier D. SARS-CoV-2 transmission modes: Why and how contamination occurs around shared meals and drinks? Food Microbiol 2023; 114:104297. [PMID: 37290873 DOI: 10.1016/j.fm.2023.104297] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 04/24/2023] [Accepted: 04/24/2023] [Indexed: 06/10/2023]
Abstract
In spite of prevention measures enacted all over the world to control the COVID-19 pandemic outbreak, including mask wearing, social distancing, hand hygiene, vaccination, and other precautions, the SARS-CoV-2 virus continues to spread globally at an unabated rate of about 1 million cases per day. The specificities of superspreading events as well as evidence of human-to-human, human-to-animal and animal-to-human transmission, indoors or outdoors, raise questions about a possibly neglected viral transmission route. In addition to inhaled aerosols, which are already recognized as key contributors to transmission, the oral route represents a strong candidate, in particular when meals and drinks are shared. In this review, we intend to discuss that significant quantities of virus dispersed by large droplets during discussions at festive gatherings could explain group contamination either directly or indirectly after deposition on surfaces, food, drinks, cutlery, and several other soiled vectors. We suggest that hand hygiene and sanitary practices around objects brought to the mouth and food also need to be taken into account in order to curb transmission.
Collapse
Affiliation(s)
| | | | - Benoit Hermant
- Risk and Capability Assessment Unit, Public Health Agency of Canada, Ottawa, ON, Canada
| | - Didier Lepelletier
- Hospital Hygiene Department, Nantes University Hospital, F-44000, Nantes, France; Nantes University, IICiMEd 1155 Lab, IRS 2 Institute, F-44093, Nantes, France.
| |
Collapse
|
2
|
Pozzetto B, Grard G, Durand G, Paty MC, Gallian P, Lucas-Samuel S, Diéterlé S, Fromage M, Durand M, Lepelletier D, Chidiac C, Hoen B, Nicolas de Lamballerie X. Arboviral Risk Associated with Solid Organ and Hematopoietic Stem Cell Grafts: The Prophylactic Answers Proposed by the French High Council of Public Health in a National Context. Viruses 2023; 15:1783. [PMID: 37766192 PMCID: PMC10536626 DOI: 10.3390/v15091783] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/01/2023] [Revised: 08/18/2023] [Accepted: 08/20/2023] [Indexed: 09/29/2023] Open
Abstract
Diseases caused by arboviruses are on the increase worldwide. In addition to arthropod bites, most arboviruses can be transmitted via accessory routes. Products of human origin (labile blood products, solid organs, hematopoietic stem cells, tissues) present a risk of contamination for the recipient if the donation is made when the donor is viremic. Mainland France and its overseas territories are exposed to a complex array of imported and endemic arboviruses, which differ according to their respective location. This narrative review describes the risks of acquiring certain arboviral diseases from human products, mainly solid organs and hematopoietic stem cells, in the French context. The main risks considered in this study are infections by West Nile virus, dengue virus, and tick-borne encephalitis virus. The ancillary risks represented by Usutu virus infection, chikungunya, and Zika are also addressed more briefly. For each disease, the guidelines issued by the French High Council of Public Health, which is responsible for mitigating the risks associated with products of human origin and for supporting public health policy decisions, are briefly outlined. This review highlights the need for a "One Health" approach and to standardize recommendations at the international level in areas with the same viral epidemiology.
Collapse
Affiliation(s)
- Bruno Pozzetto
- Haut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France; (M.D.); (D.L.); (C.C.); (B.H.)
- GIMAP Team, CIRI-Centre International de Recherche en Infectiologie, Université Jean Monnet de Saint-Etienne, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, 42023 Saint-Etienne, France
- Department of Infectious Agents and Hygiene, University Hospital of Saint-Etienne, 42055 Saint-Etienne, France
| | - Gilda Grard
- National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm), 13005 Marseille, France; (G.G.); (G.D.); (X.N.d.L.)
- French Armed Forces Biomedical Research Institute (IRBA), Valérie-André, 91220 Brétigny-sur-Orge, France
| | - Guillaume Durand
- National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm), 13005 Marseille, France; (G.G.); (G.D.); (X.N.d.L.)
- French Armed Forces Biomedical Research Institute (IRBA), Valérie-André, 91220 Brétigny-sur-Orge, France
| | - Marie-Claire Paty
- Santé Publique France, The French Public Health Agency, 94410 Saint-Maurice, France;
| | - Pierre Gallian
- Etablissement Français du Sang, 93218 Saint-Denis, France;
- Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), 13385 Marseille, France
| | | | | | - Muriel Fromage
- Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM), 93200 Saint-Denis, France;
| | - Marc Durand
- Haut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France; (M.D.); (D.L.); (C.C.); (B.H.)
| | - Didier Lepelletier
- Haut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France; (M.D.); (D.L.); (C.C.); (B.H.)
| | - Christian Chidiac
- Haut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France; (M.D.); (D.L.); (C.C.); (B.H.)
- Department of Infectious and Tropical Diseases, University Hospital of Lyon, 69002 Lyon, France
| | - Bruno Hoen
- Haut Conseil de la Santé Publique, Ministère de la Santé et de la Prévention, 75007 Paris, France; (M.D.); (D.L.); (C.C.); (B.H.)
- Department of Infectious Diseases, University Hospital of Nancy, 54500 Vandoeuvre-lès-Nancy, France
| | - Xavier Nicolas de Lamballerie
- National Reference Center for Arboviruses, National Institute of Health and Medical Research (Inserm), 13005 Marseille, France; (G.G.); (G.D.); (X.N.d.L.)
- French Armed Forces Biomedical Research Institute (IRBA), Valérie-André, 91220 Brétigny-sur-Orge, France
- Unité des Virus Émergents (UVE: Aix-Marseille Univ-IRD 190-Inserm 1207), 13385 Marseille, France
| |
Collapse
|
3
|
Monstrey SJ, Govaers K, Lejuste P, Lepelletier D, de Oliveira PR. Evaluation of the role of povidone‑iodine in the prevention of surgical site infections. Surg Open Sci 2023; 13:9-17. [PMID: 37034245 PMCID: PMC10074992 DOI: 10.1016/j.sopen.2023.03.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/19/2022] [Revised: 03/09/2023] [Accepted: 03/11/2023] [Indexed: 03/18/2023] Open
Abstract
Background The occurrence of surgical site infections (SSIs) is associated with increased risk of mortality, development of other infections, and the need for reintervention, posing a significant health burden. The aim of this review was to examine the current data and guidelines around the use of antiseptic povidone‑iodine (PVP-I) for the prevention of SSIs at each stage of surgical intervention. Methods A literature search for selected key words was performed using PubMed. Additional papers were identified based on author expertise. Results Scientific evidence demonstrates that PVP-I can be used at every stage of surgical intervention: preoperative, intraoperative, and postoperative. PVP-I is one of the most widely used antiseptics on healthy skin and mucous membranes for preoperative surgical site preparation and is associated with a low SSI rate. For intraoperative irrigation, aqueous PVP-I is the recommended agent and has been demonstrated to decrease SSIs in a range of surgical settings, and for postoperative wound healing, there is a growing body of evidence to support the use of PVP-I. Conclusions There is a need for more stringent study designs in clinical trials to enable meaningful comparisons between antiseptic agents, particularly for preoperative skin preparation. The use of a single agent (PVP-I) at each stage of surgical intervention could potentially provide advantages, including economic benefits, over agents that can only be used at discrete stages of the surgical procedure. Key message Evidence supports the use of PVP-I at all stages of surgical intervention, from preoperative measures (including skin preparation, preoperative washing, and nasal decolonization) to intraoperative irrigation, through to postoperative wound management. However, there is a need for more stringent study designs in clinical trials to enable meaningful comparisons between antiseptic agents, particularly for preoperative skin preparation.
Collapse
|
4
|
Alves PJ, Gryson L, Hajjar J, Lepelletier D, Reners M, Rodríguez Salazar J, Simon A. Role of antiseptics in the prevention and treatment of infections in nursing homes. J Hosp Infect 2023; 131:58-69. [PMID: 36216172 DOI: 10.1016/j.jhin.2022.09.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2022] [Revised: 09/16/2022] [Accepted: 09/26/2022] [Indexed: 11/07/2022]
Abstract
Inadequate infection control, wound care, and oral hygiene protocols in nursing homes pose challenges to residents' quality of life. Based on the outcomes from a focus group meeting and a literature search, this narrative review evaluates the current and potential roles of antiseptics within nursing home infection management procedures. We examine contemporary strategies and concerns within the management of meticillin-resistant Staphylococcus aureus (MRSA; including decolonization regimes), chronic wound care, and oral hygiene, and review the available data for the use of antiseptics, with a focus on povidone-iodine. Compared with chlorhexidine, polyhexanide, and silver, povidone-iodine has a broader spectrum of antimicrobial activity, with rapid and potent activity against MRSA and other microbes found in chronic wounds, including biofilms. As no reports of bacterial resistance or cross-resistance following exposure to povidone-iodine exist, it may be preferable for MRSA decolonization compared with mupirocin and chlorhexidine, which can lead to resistant MRSA strains. Povidone-iodine oral products have greater efficacy against oral pathogens compared with other antiseptics such as chlorhexidine mouthwash, highlighting the clinical benefit of povidone-iodine in oral care. Additionally, povidone-iodine-based products, including mouthwash, have demonstrated rapid in-vitro virucidal activity against SARS-CoV-2 and may help reduce its transmission if incorporated into nursing home coronavirus 2019 control protocols. Importantly, povidone-iodine activity is not adversely affected by organic material, such as that found in chronic wounds and the oral cavity. Povidone-iodine is a promising antiseptic agent for the management of infections in the nursing home setting, including MRSA decolonization procedures, chronic wound management, and oral care.
Collapse
Affiliation(s)
- P J Alves
- Wounds Research Laboratory, Centre for Interdisciplinary Research in Health (CIIS), Universidade Católica Portuguesa, Portugal.
| | - L Gryson
- Belgian Defence Medical Component, Brussels, Belgium
| | - J Hajjar
- Infection Control Practitioner, Consultant, Pau, France
| | - D Lepelletier
- Hospital Hygiene Department, Nantes University Hospital, Nantes, France
| | - M Reners
- Private Dental Practice, Liège, Belgium
| | | | - A Simon
- Infection Control Team, Groupe Hospitalier Jolimont, Haine Saint-Paul, Belgium
| |
Collapse
|
5
|
Bornand E, Letourneux F, Deschanvres C, Boutoille D, Lucet JC, Lepelletier D, Leclere B, Mayol S, Peiffer-Smadja N, Birgand G. Social representations of mask wearing in the general population during the COVID-19 pandemic. Front Public Health 2023; 11:1136980. [PMID: 37168075 PMCID: PMC10165064 DOI: 10.3389/fpubh.2023.1136980] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2023] [Accepted: 03/20/2023] [Indexed: 05/13/2023] Open
Abstract
Introduction Although one of the most prominent interventions against COVID-19, face masks seem poorly adopted by the general population. A growing body of literature has found that using face masks has social meaning. This qualitative study assessed the perceptions, representations and practices of mask wearing in the general population. Methods A qualitative survey by short semi-structured walking interviews was carried out from April to December 2021 in 11 cities in France's Pays de la Loire region. Study locations were selected for their varied geographical, social, and economic characteristics, with urbanized and rural areas. Four domains linked to perceptions of masks and wearing them were explored: (i) evolution in mask wearing, (ii) decision-making methods for wearing and not wearing; (iii) incorporating the mask into way of life; (iv) projecting into the future. Results A total of 116 people were interviewed. Masks marked a shift from the ordinary world to the pandemic. Overall, interviewees considered masks an obstacle to breathing, communication, and social interactions, leading to establishing strategies circumventing the mask mandate. Poor attention was paid to their medical usefulness as an obligatory clothing accessory. Mask-wearing decisions were driven by social relations, common sense, and vulnerability. The greater the feeling of security (i.e., being with close relatives), the less it was worn or worn properly, with decreased attention to others and their health. Most participants did not remember learning to wear a mask. Some were convinced that mask-wearing could not be learned (experiential knowledge). Institutions (school and work) played a central role by facilitating incorporation of masks into daily life. Conclusions This study emphasizes the need to reinforce the individual medical values of face masks to prevent COVID-19. Ambitious education and training programmes should be planned to learn how and when to wear masks. Institutions (work and school) may be critical for this purpose.
Collapse
Affiliation(s)
- Elvire Bornand
- Centre Nantais de Sociologie (CENS), Université de Nantes, Nantes, France
| | | | - Colin Deschanvres
- Department of Infectious Diseases, University Hospital of Nantes and CIC 1413, INSERM, Nantes, France
| | - David Boutoille
- Department of Infectious Diseases, University Hospital of Nantes and CIC 1413, INSERM, Nantes, France
| | - Jean-Christophe Lucet
- Equipe de Prévention du Risque Infectieux, Claude Bernard Hospital, Assistance Publique—Hôpitaux de Paris, Paris, France
| | - Didier Lepelletier
- Unité de Gestion du Risque Infectieux, Centre Hospitalo-Universitaire de Nantes, Nantes, France
| | - Brice Leclere
- Department of Medical Evaluation and Epidemiology, CHU Nantes, Nantes, France
| | - Séverine Mayol
- Department of Medical Evaluation and Epidemiology, CHU Nantes, Nantes, France
| | - Nathan Peiffer-Smadja
- Université Paris Cité and Université Sorbonne Paris Nord, Inserm, IAME, Paris, France
- Infectious and Tropical Diseases Department, Bichat—Claude Bernard Hospital, Assistance Publique—Hôpitaux de Paris, Paris, France
- NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, London, United Kingdom
| | - Gabriel Birgand
- NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, London, United Kingdom
- Center for the Prevention of Healthcare Associated Infections Pays de la Loire, Nantes, France
- *Correspondence: Gabriel Birgand
| |
Collapse
|
6
|
Bouchand C, Bourigault C, Le Gallou F, Corvec S, Andréo A, Lepelletier D. Systematic screening for digestive carriage of extended-spectrum β-lactamase-producing Enterobacterales (E-ESBL) at hospital readmission among patients with past history of E-ESBL colonization or infection. J Hosp Infect 2023; 131:126-128. [PMID: 36283477 DOI: 10.1016/j.jhin.2022.10.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Revised: 10/12/2022] [Accepted: 10/12/2022] [Indexed: 11/07/2022]
Abstract
BACKGROUND Extended-spectrum β-lactamase-producing Enterobacterales (E-ESBL) are commensal multidrug-resistant (MDR) bacteria of the digestive tract whose prevalence has risen sharply worldwide and in Europe over the past two decades. AIM To assess digestive carriage at hospital readmission of a large cohort of 2509 patients with E-ESBL carriage over a five-year survey; 833 (33%) patients were readmitted at least once. METHODS A retrospective, single-centre survey conducted at a tertiary care hospital in France. FINDINGS Among patients with several hospital readmissions (range: 2-13), the proportion of patients still E-ESBL-colonized at hospital readmission, detected by systematic screening for E-ESBL colonization, was >80% within an 18-month period after prior hospitalization with the first E-ESBL isolation. CONCLUSION There is a need to reconsider the continuation of systematic screening for E-ESBL colonization because of a high rate of patients still colonized at hospital readmission over a long period of time.
Collapse
Affiliation(s)
- C Bouchand
- Hospital Hygiene Department, Nantes University Hospital, Nantes, France
| | - C Bourigault
- Hospital Hygiene Department, Nantes University Hospital, Nantes, France
| | - F Le Gallou
- Hospital Hygiene Department, Nantes University Hospital, Nantes, France
| | - S Corvec
- Laboratory of Bacteriology, Nantes University Hospital, Nantes, France
| | - A Andréo
- Hospital Hygiene Department, Nantes University Hospital, Nantes, France
| | - D Lepelletier
- Hospital Hygiene Department, Nantes University Hospital, Nantes, France; Nantes Université, IIcimed 1155 Laboratory, Institut de Recherche en Santé 2, Nantes, France.
| |
Collapse
|
7
|
Lepelletier D, Chidiac C, Mansour Z, Chauvin F. New French guidelines to adapt the "Isolate/Detect/Trace" strategy for COVID-19 adult peoples or contacts considering the exponential spread of Omicron variant. Health Sci Rep 2022; 5:e612. [PMID: 36254238 PMCID: PMC9561356 DOI: 10.1002/hsr2.612] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2022] [Revised: 03/28/2022] [Accepted: 03/31/2022] [Indexed: 12/05/2022] Open
Abstract
INTRODUCTION The objectives were to elaborate new recommendations for the French Government taking into account the new epidemiological situation due to Omicron variant of SARS-CoV-2 virus and to maintain essential functions of the State through socioeconomic and health life. METHOD Two self-decision matrix were built for isolation (cases) and quarantine (contacts) and for citizen testing, respectively. The recommendations included in the two matrix were validated internally by experts and scientists from the scientist literature. RESULTS A strategic breakdown into five phases corresponding to the possible phases of Omicron variants spread was built. Exceptional and transitory derogation for essential activities was proposed in fully vaccinated professionals. Suspension of quarantine period for fully vaccinated contacts and professionals was proposed with routine self-testing program. CONCLUSION These new HCSP guidelines aims to preserve public health as a whole and to minimize the socioeconomic and health consequences linked to the emergence of the Omicron variant by making trade-offs/adaptations in dependent scientist contexts. PATIENT OR PUBLIC CONTRIBUTION HCSP scientists and experts were in charge of drafting the recommendations and promoting them to the Government for their application by regulatory decree voted by law.
Collapse
Affiliation(s)
- Didier Lepelletier
- High Council for Public HealthMinistry of HealthParisFrance,Hospital Hygiene DepartmentNantes University Hospital, France; UR 1155 – Nantes University, IICiMed, Institut de Recherche en Santé 2NantesFrance
| | - Christian Chidiac
- High Council for Public HealthMinistry of HealthParisFrance,Department of Infectious and Tropical DiseasesLyon University HospitalLyonFrance,CIRI équipe PH3ID‐INSERM‐U1111‐Université Claude Bernard Lyon 1‐CNRS ‐ UMR5308‐ENS de LyonLyonFrance
| | - Zeina Mansour
- High Council for Public HealthMinistry of HealthParisFrance,Regional Committee for Health EducationProvence Alpes Côte d'Azur (PACA)France
| | - Franck Chauvin
- High Council for Public HealthMinistry of HealthParisFrance,Centre Hygée, Institut Presage, CIC‐EC Inserm 1408University of Saint‐EtienneSaint‐EtienneFrance
| | | |
Collapse
|
8
|
Bouchand C, Andréo A, Le Gallou F, Corvec S, Bourigault C, Lepelletier D. Retrospective analysis of a large single cohort of Enterobacteriaceae producing extended-spectrum B-lactamase (E-ESBL) patients: incidence, microbiology, and mortality. Eur J Clin Microbiol Infect Dis 2022; 41:1237-1243. [PMID: 36056207 DOI: 10.1007/s10096-022-04489-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2022] [Accepted: 08/29/2022] [Indexed: 11/30/2022]
Abstract
We conducted a retrospective study from 2005 to 2019 to describe the epidemiology and mortality of enterobacterial producing extended-spectrum β-lactamase (E-ESBL) infections in our university hospital over a 17-year period of time. Clinical and microbiological data were extracted from different software used for continuous surveillance. Stool samples from systematic screening for E-ESBL colonization were excluded from the study. The incidence rate of infected patient was calculated by E-ESBL species and by year. A comparison of mortality rate in patients with bloodstream infections versus other types of infections was conducted using a Kaplan-Meier method survival curves. A log rank test (with a risk of 5%) was carried out. A total of 3324 patients with E-ESBL infection were included with an increased incidence density per 1000 days of hospitalization from 0.03 in 2005 to 0.47 in 2019. Escherichia coli was the most frequently isolated pathogen (64%). Global mortality rate was significantly higher with E. coli than with Klebsiella spp. and Enterobacter spp. (p < 0.001). Mortality was higher in patients with E-ESBL bloodstream infection than in patients with other type of E-ESBL infection (p < 0.001). Our study showed a significant increase of the E-ESBL incidence density over a 17-year period survey with a higher mortality in patients with E-ESBL bacteremia. This highlights the need to continue efforts to control the spread of these multi-resistant bacteria in our institution.
Collapse
Affiliation(s)
- Camille Bouchand
- Hospital Hygiene Department, Nantes University Hospital, 5, rue du Prof. Yves Boquien, R44093, Nantes, France
| | - Anaïs Andréo
- Hospital Hygiene Department, Nantes University Hospital, 5, rue du Prof. Yves Boquien, R44093, Nantes, France
| | - Florence Le Gallou
- Hospital Hygiene Department, Nantes University Hospital, 5, rue du Prof. Yves Boquien, R44093, Nantes, France
| | - Stéphane Corvec
- Laboratory of Bacteriology, Nantes University Hospital, R44093, Nantes, France
| | - Céline Bourigault
- Hospital Hygiene Department, Nantes University Hospital, 5, rue du Prof. Yves Boquien, R44093, Nantes, France
| | - Didier Lepelletier
- Hospital Hygiene Department, Nantes University Hospital, 5, rue du Prof. Yves Boquien, R44093, Nantes, France. .,IIcimed 1155 Laboratory, Institut de Recherche en Santé 2, Nantes Université, R44035, Nantes, France.
| |
Collapse
|
9
|
Lepelletier D, Pozzetto B, Chauvin F, Chidiac C. Management of patients with monkeypox virus (MPXV) infection and contacts in the community and in healthcare settings: A French position paper. Clin Microbiol Infect 2022; 28:1572-1577. [PMID: 36058544 PMCID: PMC9534082 DOI: 10.1016/j.cmi.2022.08.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2022] [Revised: 08/22/2022] [Accepted: 08/23/2022] [Indexed: 11/24/2022]
Abstract
Scope Since April 2022, a large number of monkeypox (MPX) cases have emerged across the globe in regions that are known to be totally free of zoonotic reservoir. The High Council for Public Health is a national institute commissioned to provide guidelines to the French Ministry of Health. The objective of these guidelines and recommendations is to inform the public, people at risk of severe MPX infection, infected patients and their families and contacts and healthcare workers in charge of infected patients. Methods A review of the literature from the MEDLINE database was carried out using the single keyword ‘monkeypox’, including recent and older articles from January 2000 to June 2022. There was no filter for the type of study, except English language. The titles and summaries of all the articles were read by the experts to select articles of interest. The High Council for Public Health brought together specialists with expertise in the field to analyse the scientific literature and international recommendations. Recommendations were classified with clinical practice methodology using four levels (strong recommendation, recommendation, optional recommendation and no recommendation) without grading the level of evidence. To develop and methodologically validate the recommendations, the Appraisal of Guidelines for Research and Evaluation Instrument (AGREE-II)chart was partially used. Questions addressed by the guidelines and recommendations (a) What are the therapeutic management measures for hospitalized patients with severe forms of MPX infection, and what are the preventive measures to protect healthcare professionals? (b) What are the isolation and prevention measures in the community for patients with mild or moderate severity MPX infection? (c) what are the preventive measures for contacts of an MPX-infected person? (d) Who should be vaccinated? (e) What are the specific prevention measures for children and schools?
Collapse
Affiliation(s)
- Didier Lepelletier
- High Council for Public Health, Ministry of Solidarity and Health, Paris, FR-75015.
| | - Bruno Pozzetto
- High Council for Public Health, Ministry of Solidarity and Health, Paris, FR-75015
| | - Franck Chauvin
- High Council for Public Health, Ministry of Solidarity and Health, Paris, FR-75015
| | - Christian Chidiac
- High Council for Public Health, Ministry of Solidarity and Health, Paris, FR-75015
| | -
- High Council for Public Health, Ministry of Solidarity and Health, Paris, FR-75015
| | -
- High Council for Public Health, Ministry of Solidarity and Health, Paris, FR-75015
| |
Collapse
|
10
|
Vignier N, Halley des Fontaines V, Billette de Villemeur A, Cazenave-Roblot F, Hoen B, Chauvin F, Lepelletier D, Chidiac C, Billaud E. Public health issues and health rendezvous for migrants from conflict zones in Ukraine: A French practice guideline. Infect Dis Now 2022; 52:193-201. [PMID: 35483634 PMCID: PMC9040487 DOI: 10.1016/j.idnow.2022.04.006] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/04/2022] [Accepted: 04/07/2022] [Indexed: 11/17/2022]
Abstract
Given the number of people leaving the war zone in Ukraine and arriving in France, the French high council for public health (HCSP) has drawn up a number of recommendations. The experts have taken into account the vulnerability of migrant populations, which is exacerbated by (a) promiscuity that increases the risk of exposure to infectious agents; (b) the psychological consequences of conflict, family separation and exile; (c) prevalence in Ukraine of communicable diseases such as (possibly multi-resistant) tuberculosis, HIV and HCV; (d) low vaccination coverage (risk of circulation of poliovirus) and (e) the risk of spreading infectious diseases (Covid-19, measles…). Consequently, experts recommend that priority be given to: (i) Initial (immediate) reception, which will help to provide emergency care and to assess immediate needs (psychological disorders, risk of medication breakdown and risk of infection); (ii) Other priority measures (vaccination catch-up, including vaccination against SARS-CoV-2 and mandatory vaccination for children's entry into school, screening for post-traumatic stress disorder and tuberculosis) must be implemented as soon as feasible. At this stage, it is imperative: To ensure coordination and access to information throughout the country, by providing medico-social support (opening of social rights and access to care); To digitize medical data for the purposes of traceability; To use professional interpreting and/or health facilitators, or else, if necessary, digital translation tools. (iii) Finally, experts stress the need for vigilance in terms of management, conservation of social rights and continuity of care after the initial period, and organization of a "health rendezvous" within four months of a migrant's entering the country.
Collapse
Affiliation(s)
- N Vignier
- Société de pathologie infectieuse de langue française, Paris, France; Centre d'investigation clinique Antilles-Guyane, CIC INSERM 1424, DRISP, centre hospitalier de Cayenne, Cayenne, French Guyana; Centre hospitalier universitaire Avicenne, AP-HP, hôpitaux universitaires Paris Seine-Saint-Denis, université Sorbonne Paris Nord, UFR SMBH, Bobigny, France; Institut convergences et migration, Aubervilliers, France.
| | | | | | - F Cazenave-Roblot
- Société de pathologie infectieuse de langue française, Paris, France; Haut Conseil de la santé publique, Paris, France; Centre hospitalier universitaire de Poitiers, Poitiers, France
| | - B Hoen
- Haut Conseil de la santé publique, Paris, France; Institut Pasteur de Paris, Paris, France
| | - F Chauvin
- Haut Conseil de la santé publique, Paris, France
| | - D Lepelletier
- Haut Conseil de la santé publique, Paris, France; Centre hospitalier universitaire de Nantes, Nantes, France
| | - C Chidiac
- Haut Conseil de la santé publique, Paris, France; Centre hospitalier universitaire de Lyon, UFR de médecine et maïeutique Lyon Sud, université Claude-Bernard-Lyon 1, université de Lyon, CIRI PHE3ID Inserm U1111, UMR5308-ENS Lyon, Lyon, France
| | - E Billaud
- Haut Conseil de la santé publique, Paris, France; Centre hospitalier universitaire de Nantes, Nantes, France
| |
Collapse
|
11
|
Monstrey SJ, Lepelletier D, Simon A, Touati G, Vogt S, Favalli F. Evaluation of the antiseptic activity of 5% alcoholic povidone-iodine solution using four different modes of application: a randomized open-label study. J Hosp Infect 2022; 123:67-73. [PMID: 35271958 DOI: 10.1016/j.jhin.2022.02.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Revised: 02/16/2022] [Accepted: 02/16/2022] [Indexed: 11/25/2022]
Abstract
BACKGROUND Before some invasive procedures, such as injections, surgical incision or intravascular catheter insertions, alcoholic antiseptics (e.g., alcoholic povidone-iodine [PVP-I]) are widely used to prevent infection. AIM This randomized, open-label study investigated the impact of mode of application (which includes both application technique and volume) on the antiseptic activity of 5% alcoholic PVP-I solution. METHODS Alcoholic PVP-I was administered on the backs of healthy adults using four modes of application: A, concentric circle method, 3mL; B, concentric circle method, 10 mL; C, back-and-forth friction method, 3 mL; D, back-and-forth friction method, 10 mL. PRIMARY ENDPOINT antiseptic activity of alcoholic PVP-I, assessed via change from baseline in log10/cm2 colony-forming units (CFU) count for total aerobic and facultative anaerobic bacteria. Safety was monitored. FINDINGS 113 healthy participants were screened; 32 were randomized. Alcoholic PVP-I showed significant antiseptic activity with all modes of application (p<0.001 for each), providing an overall mean decrease from baseline in CFU count of >3 log10/cm2 (p<0.001). Significantly greater efficacy was seen with back-and-forth friction (modes C and D) versus concentric circles (modes A and B): covariate adjusted change in log10/cm2 CFU count 0.22; 90% confidence intervals: 0.07, 0.37 (p=0.017). No safety issues were observed. CONCLUSION Alcoholic PVP-I demonstrated high antiseptic activity for all modes of application. Greater efficacy was achieved with back-and-forth friction versus concentric circles, showing that application technique may influence antiseptic activity; these findings suggest that when comparing the efficacy of antiseptic substances (e.g., alcoholic PVP-I and alcoholic chlorhexidine [CHX]), comparable application techniques should be used.
Collapse
Affiliation(s)
- Stan J Monstrey
- Burn Care Center, Plastic Surgery Department, University of Ghent, Belgium.
| | - Didier Lepelletier
- Hospital Hygiene Department and Lab EE 1701 S MiHAR, Nantes University Hospital, Nantes, France
| | - Anne Simon
- Infection Control Groupe, Hôpital de Jolimont, La Louvière, Belgium
| | - Gilles Touati
- Cardiovascular Surgery, University Hospital Amiens-Picardie (CHU Amiens-Picardie), Amiens, France
| | - Susanne Vogt
- Meda Pharma GmbH & Co. KG, A Viatris Company, Bad Homburg, Germany
| | | |
Collapse
|
12
|
Cortés Rey N, Pinelli F, van Loon FHJ, Caguioa J, Munoz Mozas G, Piriou V, Teichgräber U, Lepelletier D, Mussa B. The state of vascular access teams: Results of a European survey. Int J Clin Pract 2021; 75:e14849. [PMID: 34516704 DOI: 10.1111/ijcp.14849] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/11/2021] [Revised: 08/26/2021] [Accepted: 09/10/2021] [Indexed: 12/01/2022] Open
Abstract
BACKGROUND Many European health institutions have appointed multidisciplinary teams for the general management of vascular access to help improve efficiency, patient safety and reduce costs. Vascular access teams (VATs), or infusion teams, are specifically trained groups of healthcare professionals who assess, place, manage and monitor various outcomes and aspects of vascular access care. OBJECTIVE To assess the current landscape of vascular access management as a discipline across Europe. METHODS A Faculty of European VAT leads and experts developed a survey of 20 questions which was disseminated across several European countries. Questions focused on respondent and institution profile, vascular access device selection and placement, monitoring and reporting of complications, and access to training and education. The 1449 respondents included physicians, nurses, anaesthetists, radiologists and surgeons from public and private institutions ranging in size. RESULTS Availability of dedicated VATs vary by country, institution size, and institution type. Institutions with a VAT are more likely to utilise a tool (eg, algorithm or guideline) to determine the appropriate vascular access device (55% vs 38%, P < .0002) and to have feedback on systematic monitoring of complications (40% vs 28%, P = .015). Respondents from institutions with a VAT are more likely to have received training on vascular access management (79% vs 53%, P < .0001) and indicated that the VAT was a source of support when difficulties arise. CONCLUSION The survey results highlight some of the potential benefits of implementing a dedicated VAT including the use of a broader range of vascular access devices, increased awareness of the presence of vascular access policies, increased the likelihood of recent vascular access training, and increased rates of systematic monitoring of associated complications. The study reveals potential areas for further focus in the field of vascular access care, specifically examining the direct impact of vascular access teams.
Collapse
Affiliation(s)
- Noemí Cortés Rey
- Hospital Teresa Herrera, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain
| | | | | | - Jennifer Caguioa
- Kings College Hospital NHS Foundation Trust, London, United Kingdom
| | | | - Vincent Piriou
- Hospices Civils de Lyon, Université Claude Bernard Lyon-1, Lyon, France
| | | | | | | |
Collapse
|
13
|
Rahal A, Andreo A, Le Gallou F, Bourigault C, Bouchand C, Ferriot C, Corvec S, Guillouzouic A, Gras-Leguen C, Launay E, Flamant C, Lepelletier D. Enterobacter cloacae complex outbreak in a neonatal intensive care unit: multifaceted investigations and preventive measures are needed. J Hosp Infect 2021; 116:87-90. [PMID: 34419520 DOI: 10.1016/j.jhin.2021.07.012] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2021] [Revised: 07/21/2021] [Accepted: 07/21/2021] [Indexed: 10/20/2022]
Abstract
We report the investigation to control an Enterobacter cloacae complex outbreak in a neonatal intensive care unit from November 2020 to February 2021. Pulsed-field gel electrophoresis showed that five of eight cases were infected with a clonal strain. Breast pumps, shared among mothers in the unit, could have contributed to the spread of the clonal spread.
Collapse
Affiliation(s)
- A Rahal
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - A Andreo
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - F Le Gallou
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - C Bourigault
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - C Bouchand
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - C Ferriot
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - S Corvec
- Laboratory of Bacteriology, Nantes University Hospital, Nantes, France
| | - A Guillouzouic
- Laboratory of Bacteriology, Nantes University Hospital, Nantes, France
| | - C Gras-Leguen
- General Paediatrics and Paediatric Infectious Disease Unit, Nantes University Hospital, Nantes, France
| | - E Launay
- General Paediatrics and Paediatric Infectious Disease Unit, Nantes University Hospital, Nantes, France
| | - C Flamant
- Neonatal Intensive Care Unit, Nantes University Hospital, Nantes, France
| | - D Lepelletier
- Infection Control Department, Nantes University Hospital, Nantes, France; MiHar Laboratory, University of Nantes, Nantes, France.
| |
Collapse
|
14
|
Guesneau C, Boureau AS, Bourigault C, Berrut G, Lepelletier D, de Decker L, Chapelet G. Risk Factors Associated with 30-Day Mortality in Older Patients with Influenza. J Clin Med 2021; 10:jcm10163521. [PMID: 34441817 PMCID: PMC8396973 DOI: 10.3390/jcm10163521] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2021] [Revised: 07/27/2021] [Accepted: 08/02/2021] [Indexed: 12/01/2022] Open
Abstract
Background: Influenza is a common viral condition, but factors related to short-term mortality have not been fully studied in older adults. Our objective was to determine whether there is an association between geriatric factors and 30-day mortality. Methods: This was a retrospective cohort design. All patients aged 75 years and over, with a diagnosis of influenza confirmed by a positive RT-PCR, were included. The primary endpoint was death within the 30 days after diagnosis. Results: 114 patients were included; 14 (12.3%) patients died within 30 days. In multivariate analysis these patients were older (OR: 1.37 95% CI (1.05, 1.79), p = 0.021), and had a lower ADL score (OR: 0.36 95% CI (0, 17; 0.75), p = 0.006), and a higher SOFA score (OR: 2.30 95% CI (1.07, 4.94), p = 0.03). Oseltamivir treatment, initiated within the first 48 h, was independently associated with survival (OR: 0.04 95% CI (0.002, 0.78), p = 0.034). Conclusions: Identification of mortality risk factors makes it possible to consider specific secondary prevention measures such as the rapid introduction of antiviral treatment. Combined with primary prevention, these measures could help to limit the mortality associated with influenza in older patients.
Collapse
Affiliation(s)
- Charles Guesneau
- Clinical Gerontology Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, F-44000 Nantes, France
| | - Anne Sophie Boureau
- Clinical Gerontology Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, F-44000 Nantes, France
| | - Céline Bourigault
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance Bacterienne), Institut de Recherche en Santé (IRS2), 22 Boulevard Bénoni-Goullin, F-44200 Nantes, France
- Bacteriology and Infection Control Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, F-44000 Nantes, France
| | - Gilles Berrut
- Clinical Gerontology Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, F-44000 Nantes, France
| | - Didier Lepelletier
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance Bacterienne), Institut de Recherche en Santé (IRS2), 22 Boulevard Bénoni-Goullin, F-44200 Nantes, France
- Bacteriology and Infection Control Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, F-44000 Nantes, France
| | - Laure de Decker
- Clinical Gerontology Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, F-44000 Nantes, France
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance Bacterienne), Institut de Recherche en Santé (IRS2), 22 Boulevard Bénoni-Goullin, F-44200 Nantes, France
| | - Guillaume Chapelet
- Clinical Gerontology Department, Nantes University Hospital, 1 Place Alexis-Ricordeau, F-44000 Nantes, France
- Université de Nantes, EE MiHAR (Microbiotes, Hôtes, Antibiotiques et Résistance Bacterienne), Institut de Recherche en Santé (IRS2), 22 Boulevard Bénoni-Goullin, F-44200 Nantes, France
| |
Collapse
|
15
|
Munir MT, Maneewan N, Pichon J, Gharbia M, Oumarou-Mahamane I, Baude J, Thorin C, Lepelletier D, Le Pape P, Eveillard M, Irle M, Pailhoriès H, Aviat F, Belloncle C, Federighi M, Dubreil L. Confocal spectral microscopy, a non-destructive approach to follow contamination and biofilm formation of mCherry Staphylococcus aureus on solid surfaces. Sci Rep 2021; 11:15574. [PMID: 34341378 PMCID: PMC8329050 DOI: 10.1038/s41598-021-94939-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2021] [Accepted: 07/01/2021] [Indexed: 01/23/2023] Open
Abstract
Methods to test the safety of wood material for hygienically sensitive places are indirect, destructive and limited to incomplete microbial recovery via swabbing, brushing and elution-based techniques. Therefore, we chose mCherry Staphylococcus aureus as a model bacterium for solid and porous surface contamination. Confocal spectral laser microscope (CSLM) was employed to characterize and use the autofluorescence of Sessile oak (Quercus petraea), Douglas fir (Pseudotsuga menziesii) and poplar (Populus euramericana alba L.) wood discs cut into transversal (RT) and tangential (LT) planes. The red fluorescent area occupied by bacteria was differentiated from that of wood, which represented the bacterial quantification, survival and bio-distribution on surfaces from one hour to one week after inoculation. More bacteria were present near the surface on LT face wood as compared to RT and they persisted throughout the study period. Furthermore, this innovative methodology identified that S. aureus formed a dense biofilm on melamine but not on oak wood in similar inoculation and growth conditions. Conclusively, the endogenous fluorescence of materials and the model bacterium permitted direct quantification of surface contamination by using CSLM and it is a promising tool for hygienic safety evaluation.
Collapse
Affiliation(s)
| | | | - Julien Pichon
- UMR703 PAnTher APEX, INRAE/ONIRIS - La Chantrerie, 101 Route de Gachet, 44307, Nantes, France
| | | | | | - Jessica Baude
- CIRI, Inserm U1111, Lyon 1 University, ENS Lyon, CNRS UMR 5308, Lyon, France
| | | | | | - Patrice Le Pape
- EA 1155 IICiMed, IRS 2, University of Nantes, 44200, Nantes, France
| | - Matthieu Eveillard
- CRCINA, Inserm, University of Nantes, University of Angers, 44200, Angers, France.,Laboratory of Bacteriology-Hygiene, University Hospital of Angers, 49933, Angers, France
| | - Mark Irle
- LIMBHA, Ecole Supérieure du Bois, 44000, Nantes, France
| | - Hélène Pailhoriès
- Laboratory of Bacteriology-Hygiene, University Hospital of Angers, 49933, Angers, France.,HIFIH, UPRES EA3859, SFR 4208, University of Angers, Angers, France
| | - Florence Aviat
- Your ResearcH-Bio-Scientific, 44430, Le Landreau, France
| | | | | | - Laurence Dubreil
- UMR703 PAnTher APEX, INRAE/ONIRIS - La Chantrerie, 101 Route de Gachet, 44307, Nantes, France.
| |
Collapse
|
16
|
Birgand G, Mutters NT, Otter J, Eichel VM, Lepelletier D, Morgan DJ, Lucet JC. Variation of National and International Guidelines on Respiratory Protection for Health Care Professionals During the COVID-19 Pandemic. JAMA Netw Open 2021; 4:e2119257. [PMID: 34347062 PMCID: PMC8339937 DOI: 10.1001/jamanetworkopen.2021.19257] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
This systematic review assesses variation in international and national guidelines on respiratory protection for health care professionals during the COVID-19 pandemic.
Collapse
Affiliation(s)
- Gabriel Birgand
- National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London, United Kingdom
- Regional Center for Infection Prevention and Control Pays de la Loire, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - Nico T. Mutters
- Institute for Hygiene and Public Health, University Hospital Bonn, Bonn, Germany
| | - Jonathan Otter
- National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance at Imperial College London, London, United Kingdom
| | - Vanessa M. Eichel
- Centre for Infectious Diseases, Heidelberg University Hospital, Heidelberg, Germany
| | - Didier Lepelletier
- Infection Control Unit, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - Daniel J. Morgan
- University of Maryland School of Medicine, Baltimore
- VA Maryland Healthcare System, Baltimore
| | - Jean-Christophe Lucet
- Infection Antimicrobials Modelling Evolution, French Institute for Medical Research, University Paris Diderot, Sorbonne Paris Cité, Paris, France
- Infection Control Unit, Hôpital Bichat-Claude Bernard, Assistance Publique-Hôpitaux de Paris, Paris, France
| |
Collapse
|
17
|
Mussa B, Pinelli F, Cortés Rey N, Caguioa J, Van Loon FHJ, Munoz Mozas G, Teichgräber U, Lepelletier D. Qualitative interviews and supporting evidence to identify the positive impacts of multidisciplinary vascular access teams. Hosp Pract (1995) 2021; 49:141-150. [PMID: 33781151 DOI: 10.1080/21548331.2021.1909897] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
BACKGROUND Vascular access by means of intravenous catheters is essential for the safe, effective and cost-efficient delivery of intravenous fluids, antibiotics, nutrition and chemotherapy, but the use of these devices is not without complications. PURPOSE A faculty of multidisciplinary European vascular access team (VAT) Leads/Members and experts sought to reframe how the implementation of a VAT could have positive impacts on patients and hospitals. METHODS Interview data from a Faculty of nine VAT Leads/Members and experts from six European countries on the impact of multidisciplinary VATs in modern healthcare were assessed. A literature search was conducted that included Medline®-cited peer-reviewed articles published in the past 10 years in order to identify impact data and post-implementation of a multidisciplinary VAT that support the benefits to patient safety and satisfaction and to hospital efficiencies reported in the interview program. RESULTS While VATs vary in structure and function, clarity of purpose and supportive training and education are key. Barriers to the implementation of VATs show commonality across countries, such as lack of investment, insufficient training and lack of awareness. Proven markers of VAT success include rapid referrals, improved patient outcomes and improved organizational efficiency. Standardization of outcomes data capture, processing and reporting are key to monitoring performance against baseline. Awareness of the cost of complications arising from inappropriate choice and placement, and poor care and maintenance, of the vascular access device must be raised. CONCLUSIONS The implementation of VATs can positively impact patient safety and satisfaction, improve organizational efficiencies and cost-effectiveness, and could create new opportunities for in- and outpatient services, beneficial to both patients and institutions.
Collapse
Affiliation(s)
- Baudolino Mussa
- Department of Surgical Sciences, University of Turin, Turin, Italy
| | | | - Noemí Cortés Rey
- Servicio de Reanimación, Hospital Teresa Herrera, Complejo Hospitalario Universitario de A Coruña, Spain
| | - Jennifer Caguioa
- Haematology Outpatients Clinic, Supportive Therapy Unit and the Chemotherapy Unit, Kings College Hospital NHS Foundation Trust, UK
| | | | | | | | - Didier Lepelletier
- Bacteriology and Hospital Hygiene Department, Nantes University Hospital
| |
Collapse
|
18
|
Bompas V, Andréo A, Bouchand C, Rahal A, Ferriot C, Le Gallou F, Guille des Buttes AC, Quimbre M, Bodet N, Bourigault C, Lepelletier D. Day surgery: should we be worried about the occurrence of surgical site infection in outpatients? J Hosp Infect 2021; 114:185-186. [PMID: 33901581 DOI: 10.1016/j.jhin.2021.04.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Revised: 04/12/2021] [Accepted: 04/12/2021] [Indexed: 10/21/2022]
Affiliation(s)
- V Bompas
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - A Andréo
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - C Bouchand
- MiHAR Laboratory, University of Nantes, Nantes, France
| | - A Rahal
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - C Ferriot
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - F Le Gallou
- Infection Control Department, Nantes University Hospital, Nantes, France
| | | | - M Quimbre
- Day Surgery Department, Nantes University Hospital, Nantes, France
| | - N Bodet
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - C Bourigault
- Infection Control Department, Nantes University Hospital, Nantes, France
| | - D Lepelletier
- Infection Control Department, Nantes University Hospital, Nantes, France; MiHAR Laboratory, University of Nantes, Nantes, France.
| |
Collapse
|
19
|
Grégoire M, Berteau F, Bellouard R, Lebastard Q, Aubert P, Gonzales J, Javaudin F, Bessard A, Bemer P, Batard É, Lepelletier D, Neunlist M, Montassier E, Dailly É. A murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment. Comput Struct Biotechnol J 2021; 19:1423-1430. [PMID: 33777338 PMCID: PMC7961304 DOI: 10.1016/j.csbj.2021.02.019] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2020] [Revised: 02/23/2021] [Accepted: 02/23/2021] [Indexed: 01/21/2023] Open
Abstract
Background The globally increasing resistance due to extended-spectrum beta-lactamase producing Enterobacteriaceae is a major concern. The objective of this work was to develop a murine model to study the gut bacteria parameters during complex antibiotics like cefotaxime and ceftriaxone treatment and to compare the fecal carriage of ESBL-producing Enterobacteriaceae. Methods SWISS mice were treated either with ceftriaxone or with cefotaxime or with NaCl 0.9% as a control group from day 1 to day 5. We performed a gavage at day 4 with a Klebsiella pneumonia CTX-M9. We collected stools and performed pharmacological measurements, cultures and 16S rRNA gene amplification and sequencing during the 12 days of the stool collection. Results Mice treated with ceftriaxone were more colonized than mice treated with cefotaxime after gavage (p-value = 0.008; Kruskal-Wallis test). Ceftriaxone and cefotaxime were both excreted in large quantity in gut lumen but they drove architecture of the gut microbiota in different trajectories. Highest levels of colonization were associated with particular microbiota composition using principal coordinate analysis (PCoA) which were more often achieved in ceftriaxone-treated mice and which were preceded by highest fecal antibiotics concentrations in both cefotaxime or ceftriaxone groups. Using LEfSe, we found that twelve taxa were significantly different between cefotaxime and ceftriaxone-treated mice. Using SplinectomeR, we found that relative abundances of Klebsiella were significantly higher in CRO than in CTX-treated mice (p-value = 0.01). Conclusion Ceftriaxone selects a particular microbial community and its substitution for cefotaxime could prevent the selection of extended-spectrum beta-lactamase producing Enterobacteriaceae.
Collapse
Affiliation(s)
- Matthieu Grégoire
- Clinical Pharmacology Department, CHU Nantes, Nantes, France.,EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France
| | - Florian Berteau
- EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France
| | - Ronan Bellouard
- Clinical Pharmacology Department, CHU Nantes, Nantes, France.,EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France
| | - Quentin Lebastard
- EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France.,Emergency Department, CHU Nantes, Nantes, France
| | - Philippe Aubert
- UMR Inserm 1235, The Enteric Nervous System in Gut and Brain Disorders, Nantes University, France
| | - Jacques Gonzales
- UMR Inserm 1235, The Enteric Nervous System in Gut and Brain Disorders, Nantes University, France
| | - François Javaudin
- EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France.,Emergency Department, CHU Nantes, Nantes, France
| | - Anne Bessard
- UMR Inserm 1235, The Enteric Nervous System in Gut and Brain Disorders, Nantes University, France
| | - Pascale Bemer
- EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France.,Bacteriology and Infection Control Department, CHU Nantes, Nantes, France
| | - Éric Batard
- EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France.,Emergency Department, CHU Nantes, Nantes, France
| | - Didier Lepelletier
- EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France.,Bacteriology and Infection Control Department, CHU Nantes, Nantes, France
| | - Michel Neunlist
- UMR Inserm 1235, The Enteric Nervous System in Gut and Brain Disorders, Nantes University, France
| | - Emmanuel Montassier
- EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France.,Emergency Department, CHU Nantes, Nantes, France
| | - Éric Dailly
- Clinical Pharmacology Department, CHU Nantes, Nantes, France.,EE1701, Microbiotas Hosts Antibiotics and Bacterial Resistances, Nantes University, France
| |
Collapse
|
20
|
Bukasa JC, Muteba P, Kazadi A, Lepelletier D, Ilunga F, Mutombo A, Kamanya AN, Bandimuna A, Mbo SN, Stany W. [A study of the incidence of nosocomial infections and the associated risk factors in the city of Mbujimayi, Democratic Republic of Congo]. Pan Afr Med J 2021; 38:95. [PMID: 33889261 PMCID: PMC8035685 DOI: 10.11604/pamj.2021.38.95.15044] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2018] [Accepted: 12/28/2020] [Indexed: 11/16/2022] Open
Abstract
Introduction cette étude vise à déterminer l´incidence des infections nosocomiales et les facteurs de risque chez les accouchées et les nouveau-nés dans les maternités de la ville de Mbujimayi en République Démocratique du Congo. Méthodes il s´agit d´une étude descriptive longitudinale d´incidence et facteurs de risque des infections nosocomiales dans les 231 maternités, qui a été réalisée chez les sujets indemnes de la pathologie au départ qu´on devrait suivre en utilisant la collecte hebdomadaire des données pendant 6 mois. Les critères utilisés pour la collecte des données étaient ceux de l´Organisation Mondiale de la Santé (OMS) basés sur les définitions simplifiées pouvant être utiles pour certains établissements n´ayant pas accès à des techniques diagnostiques poussées. Résultats l´incidence globale des infections nosocomiales chez les accouchées est de 24,8% et de 22,3% chez les nouveau-nés. Les facteurs de risque significatif d´infection nosocomiale au couple étaient les manœuvres instrumentales (p=0,005; OR=2,7; IC95% [1,3-5,4]), la césarienne faite en urgence (p=0,000; OR=2,3; IC95% [1,7-3,9]), l´utilisation d´un même flacon de collyre chez tous les bébés (p=0,004; OR=2,7; IC95% [1,4-5,5]) et l´élevage du prématuré hors couveuse (p=0,000; OR=2,61; IC95% [1,73-3,92]). Conclusion la réalisation d'enquêtes d'incidence (ou à défaut de prévalence) régulières est indispensable pour évaluer les effets des actions d'information, de sensibilisation et de formation qui pourront être mises en place pour lutter contre les infections acquises à l'hôpital.
Collapse
Affiliation(s)
- Jean Christophe Bukasa
- Institut Supérieur des Techniques Médicales de Mbujimayi, Mbujimayi, République Démocratique du Congo
| | - Pascal Muteba
- Institut Supérieur des Techniques Médicales de Mbujimayi, Mbujimayi, République Démocratique du Congo
| | - André Kazadi
- Institut Supérieur des Techniques Médicales de Mbujimayi, Mbujimayi, République Démocratique du Congo
| | - Didier Lepelletier
- Laboratoire Emergent MiHAR, UFR Médecine, Université de Nantes, IRS2-Nantes Biotech, Nantes, France
| | - Félicien Ilunga
- Institut Supérieur des Techniques Médicales de Kinshasa, Kinshasa, République Démocratique du Congo
| | - André Mutombo
- Université Officielle de Mbujimayi, Mbujimayi, République Démocratique du Congo
| | - Axel Ngoyi Kamanya
- Institut Supérieur des Techniques Médicales de Kabinda, Kabinda, République Démocratique du Congo
| | - Angélique Bandimuna
- Institut Supérieur des Techniques Médicales de Kabinda, Kabinda, République Démocratique du Congo
| | - Senghor Ngoyi Mbo
- Institut Supérieur des Techniques Médicales de Kabinda, Kabinda, République Démocratique du Congo
| | - Wembonyama Stany
- Ecole de Santé Publique, Université de Lubumbashi, Lubumbashi, République Démocratique du Congo
| |
Collapse
|
21
|
T Munir M, Aviat F, Lepelletier D, Pape PL, Dubreil L, Irle M, Federighi M, Belloncle C, Eveillard M, Pailhoriès H. Wood materials for limiting the bacterial reservoir on surfaces in hospitals: would it be worthwhile to go further? Future Microbiol 2020; 15:1431-1437. [PMID: 33156723 DOI: 10.2217/fmb-2019-0339] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
Aim: To assess the activity of Quercus petraea (oak) on five bacterial species/genus frequently involved in hospital-acquired infections for evaluating the interest of going further in exploring the possibilities of using untreated wood as a material in the hospital setting. Materials & methods: We studied the activity of Q. petraea by the disk diffusion method. Results: Q. petraea was active on Staphylococcus aureus and Acinetobacter coalcoaceticus-baumannii complex, two bacterial species particularly resistant in the hospital environment, independently from their resistance to antibiotics, and was slightly active on Pseudomonas aeruginosa. Concurrently, Q. petraea was not active on Enterococci and Escherichia coli. Conclusion: Overall, untreated wood material presented antimicrobial properties that could have an impact on the cross-transmission of certain bacterial species in healthcare settings.
Collapse
Affiliation(s)
- Muhammad T Munir
- Laboratoire Innovation Matériau Bois Habitat Apprentissage (LIMBHA), Ecole Supérieure du Bois, 7 Rue Christian Pauc, 44000 Nantes, France
| | - Florence Aviat
- Your ResearcH-Bio-Scientific, 307 La Gauterie, 44430 Le Landreau, France
| | - Didier Lepelletier
- Laboratoire MiHAR EE 1701 S, Institut de Recherche en Santé 2, Université de Nantes, 22 Boulevard Benoni-Goullin, 44200 Nantes, France
| | - Patrice Le Pape
- EA 1155 IICiMed, Institut de Recherche en Santé 2, Université de Nantes, 22 Boulevard Benoni-Goullin, 44200 Nantes, France
| | - Laurence Dubreil
- PAnTher, INRA, École Nationale Vétérinaire, Agro-alimentaire et de l'alimentation Nantes Atlantique (Oniris), Université Bretagne Loire (UBL), Nantes, F-44307, France
| | - Mark Irle
- Laboratoire Innovation Matériau Bois Habitat Apprentissage (LIMBHA), Ecole Supérieure du Bois, 7 Rue Christian Pauc, 44000 Nantes, France
| | - Michel Federighi
- UMR INRA 1014 SECALIM, Oniris, Route de Gachet, CS 40706, 44307 Nantes Cedex 03, France
| | - Christophe Belloncle
- Laboratoire Innovation Matériau Bois Habitat Apprentissage (LIMBHA), Ecole Supérieure du Bois, 7 Rue Christian Pauc, 44000 Nantes, France
| | - Matthieu Eveillard
- CRCINA, Inserm, Université de Nantes, Université d'Angers, Angers, 44200 Nantes, France
| | - Hélène Pailhoriès
- Laboratoire de Bactériologie-Hygiène, Centre Hospitalier Universitaire, 4 Rue Larrey 49933 Angers Cedex, France
| |
Collapse
|
22
|
Ong C, Lucet JC, Bourigault C, Birgand G, Aho S, Lepelletier D. Staphylococcus aureus nasal decolonization before cardiac and orthopaedic surgeries: first descriptive survey in France. J Hosp Infect 2020; 106:332-334. [PMID: 32805310 DOI: 10.1016/j.jhin.2020.08.008] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2020] [Accepted: 08/10/2020] [Indexed: 11/25/2022]
Abstract
The objective was to describe French hospital nasal screening and decolonization procedures before clean surgery procedures. Information for participants was sent to the French Society for Infection Control members in June 2018. Seventy hospitals participated in the survey; 40% (N = 28) declared having institutional decolonization procedures: 64% (N = 18) in orthopaedic and 56% (N = 15) in cardiac surgeries. All hospitals used mupirocin for nasal decolonization and body decolonization with chlorhexidine (N = 16) or povidone iodine (N = 10). This study is the first to be performed in France giving information in this field. Screening/decolonization procedures are heterogeneous and the evaluation of their clinical impact remains complex.
Collapse
Affiliation(s)
- C Ong
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - J-C Lucet
- Infection Control Unit UHLIN, Bichat Hospital, AP-HP Paris, Paris, France
| | - C Bourigault
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - G Birgand
- Centre for Infection Control and Prevention, Pays de la Loire, Nantes, France
| | - S Aho
- Epidemiology and Infection Control Department, Dijon University Hospital, Dijon, France
| | - D Lepelletier
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France; MiHAR lab, University of Nantes, Nantes, France.
| |
Collapse
|
23
|
Le Bastard Q, Chapelet G, Birgand G, Hillmann BM, Javaudin F, Hayatgheib N, Bourigault C, Bemer P, De Decker L, Batard E, Lepelletier D, Montassier E. Gut microbiome signatures of nursing home residents carrying Enterobacteria producing extended-spectrum β-lactamases. Antimicrob Resist Infect Control 2020; 9:107. [PMID: 32665016 PMCID: PMC7359458 DOI: 10.1186/s13756-020-00773-y] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2020] [Accepted: 07/03/2020] [Indexed: 11/28/2022] Open
Abstract
BACKGROUND The prevalence of extended beta-lactamase producing Enterobacteriaceae (ESBL-E) has been constantly increasing over the last few decades. These microorganisms that have acquired broad antibiotic resistance are now common human pathogens. Changes in the gut microbiome, induced by antibiotics or other drugs, enable expansion of these microorganisms, but the mechanisms are not yet fully understood. OBJECTIVES The main objective was to identify specific bacteria and functional pathways and genes characterizing the gut microbiome of nursing home residents carrying ESBL-E, using metagenomics. SUBJECTS AND METHODS We included 144 residents living in two different nursing homes. All fecal samples were screened for ESBL-E and gut microbiome was characterized using shallow shotgun metagenomic DNA sequencing. RESULTS Ten nursing home residents were colonized by ESBL-E, namely Escherichia coli, Klebsiella pneumoniae and Enterobacter cloacae species, and were compared to non-carriers. We found that ESBL-E carriers had an alteration in within-sample diversity. Using a bootstrap algorithm, we found that the gut microbiome of ESBL-E carriers was depleted in butyrate-producing species, enriched in succinate-producing species and enriched in pathways involved in intracellular pH homeostasis compared to non-carriers individuals. Several energy metabolism pathways were overrepresented in ESBL-E carriers suggesting a greater ability to metabolize multiple microbiota and mucus layer-derived nutrients. CONCLUSIONS The gut microbiome of ESBL-E carriers in nursing homes harbors specific taxonomic and functional characteristics, conferring an environment that enables Enterobacteriaceae expansion. Here we describe new functional features associated with ESBL-E carriage that could help us to elucidate the complex interactions leading to colonization persistence in the human gut microbiota.
Collapse
Affiliation(s)
- Quentin Le Bastard
- MiHAR lab, Université de Nantes, 44000, Nantes, France.
- Department of Emergency Medicine, CHU Nantes, Nantes University Hospital, 44000, Nantes, France.
| | - Guillaume Chapelet
- MiHAR lab, Université de Nantes, 44000, Nantes, France
- Pole de gérontologie clinique, Nantes University Hospital, 44000, Nantes, France
| | - Gabriel Birgand
- MiHAR lab, Université de Nantes, 44000, Nantes, France
- Regional Infection Control Centre, Pays de la Loire, Nantes, France
| | - Benjamin M Hillmann
- Department of Computer Science and Engineering, University of Minnesota, Minneapolis, Minnesota, USA
| | - François Javaudin
- MiHAR lab, Université de Nantes, 44000, Nantes, France
- Department of Emergency Medicine, CHU Nantes, Nantes University Hospital, 44000, Nantes, France
| | | | - Céline Bourigault
- MiHAR lab, Université de Nantes, 44000, Nantes, France
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - Pascale Bemer
- MiHAR lab, Université de Nantes, 44000, Nantes, France
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - Laure De Decker
- Pole de gérontologie clinique, Nantes University Hospital, 44000, Nantes, France
| | - Eric Batard
- MiHAR lab, Université de Nantes, 44000, Nantes, France
- Department of Emergency Medicine, CHU Nantes, Nantes University Hospital, 44000, Nantes, France
| | - Didier Lepelletier
- MiHAR lab, Université de Nantes, 44000, Nantes, France
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - Emmanuel Montassier
- MiHAR lab, Université de Nantes, 44000, Nantes, France.
- Department of Emergency Medicine, CHU Nantes, Nantes University Hospital, 44000, Nantes, France.
| |
Collapse
|
24
|
Birgand G, Haudebourg T, Grammatico-Guillon L, Moret L, Gouin F, Mauduit N, Leux C, Le Manach Y, Tavernier E, Giraudeau B, Lepelletier D, Lucet JC. Intraoperative Door Openings and Surgical Site Infection: A Causal Association? Clin Infect Dis 2020; 71:469-470. [PMID: 31563935 DOI: 10.1093/cid/ciz954] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- Gabriel Birgand
- Centre d'Appui à la Prévention des Infections Associées aux Soins (CPias), Pays de la Loire, Nantes University Hospital, Nantes, France.,Health Protection Research Unit, Imperial College London, London, United Kingdom
| | - Thomas Haudebourg
- Centre d'Appui à la Prévention des Infections Associées aux Soins (CPias), Pays de la Loire, Nantes University Hospital, Nantes, France
| | - Leslie Grammatico-Guillon
- Service de Santé Publique, Unité Régionale d'Epidémiologie Hospitalière, CHU, Université de Tours, Tours, France
| | - Leila Moret
- Service de Santé Publique, Nantes University Hospital, Nantes, France
| | - François Gouin
- Service de Chirurgie Orthopédique, Nantes University Hospital, Nantes, France
| | - Nicolas Mauduit
- Service d'Information Médicale, Nantes University Hospital, Nantes, France
| | - Christophe Leux
- Service d'Information Médicale, Nantes University Hospital, Nantes, France
| | - Yannick Le Manach
- Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, Perioperative Medicine and Surgical Research Unit, Hamilton, Ontario, Canada
| | | | - Bruno Giraudeau
- INSERM CIC 1415, CHRU de Tours, Tours, France.,Université de Tours, Université de Nantes, INSERM SPHERE U1246, Tours, France
| | | | | |
Collapse
|
25
|
Trang-Poisson C, Kerdreux E, Poinas A, Planche L, Sokol H, Bemer P, Cabanas K, Hivernaud E, Biron L, Flet L, Montassier E, Le Garcasson G, Chiffoleau A, Jobert A, Lepelletier D, Caillon J, Le Pape P, Imbert BM, Bourreille A. Impact of fecal microbiota transplantation on chronic recurrent pouchitis in ulcerative colitis with ileo-anal anastomosis: study protocol for a prospective, multicenter, double-blind, randomized, controlled trial. Trials 2020; 21:455. [PMID: 32493442 PMCID: PMC7267479 DOI: 10.1186/s13063-020-04330-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2020] [Accepted: 04/18/2020] [Indexed: 02/07/2023] Open
Abstract
BACKGROUND Almost 15% of patients with ulcerative colitis (UC) will require a proctocolectomy with ileal pouch-anal anastomosis (IPAA) as a result of fulminant colitis, dysplasia, cancer, or medical refractory diseases. Around 50% will experience pouchitis, an idiopathic inflammatory condition involving the ileal reservoir, responsible for digestive symptoms, deterioration in quality of life, and disability. Though the majority of initial cases of pouchitis are easily managed with a short course of antibiotics, in about 10% of cases, inflammation of the pouch becomes chronic with very few treatments available. Previous studies have suggested that manipulating the composition of intestinal flora through antibiotics, probiotics, and prebiotics achieved significant results for treating acute episodes of UC-associated pouchitis. However, there is currently no established effective treatment for chronic antibiotic-dependent pouchitis. Fecal microbiota transplantation (FMT) is a novel therapy involving the transfer of normal intestinal flora from a healthy donor to a patient with a medical condition potentially caused by the disrupted homeostasis of intestinal microbiota or dysbiosis. METHODS Our project aims to compare the delay of relapse of chronic recurrent pouchitis after FMT versus sham transplantation. Forty-two patients with active recurrent pouchitis after having undergone an IPAA for UC will be enrolled at 12 French centers. The patients who respond to antibiotherapy will be randomized at a ratio of 1:1 to receive either FMT or sham transplantation. DISCUSSION On April 30, 2014, the World Health Organization published an alarming report on antibiotic resistance. Finding an alternative medical treatment to antibiotics in order to prevent relapses of pouchitis is therefore becoming increasingly important given the risk posed by multiresistant bacteria. Moreover, if the results of this study are conclusive, FMT, which is less expensive than biologics, could become a routine treatment in the future. TRIAL REGISTRATION ClinicalTrials.gov, NCT03524352. Registered on 14 May 2018.
Collapse
Affiliation(s)
- Caroline Trang-Poisson
- Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.,Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France
| | - Elise Kerdreux
- Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.,Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France
| | - Alexandra Poinas
- Clinical Investigation Centre CIC1413, CHU Nantes and INSERM, Nantes, France.
| | - Lucie Planche
- Methodology and Biostatistics Unit, Delegation to Clinical Research and Innovation for CHU Nantes and Vendée departmental Hospital, Nantes, La Roche sur Yon, France
| | - Harry Sokol
- Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, AP-HP, Hôpital Saint Antoine, Gastroenterology & Nutrition Department, F-75012, Paris, France
| | - Pascale Bemer
- MiHAR lab, Nantes University, 44000, Nantes, France.,Department of Emergency Medicine, CHU Nantes, Nantes, France
| | - Karine Cabanas
- Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.,Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France
| | - Eliane Hivernaud
- Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.,Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France
| | | | | | - Emmanuel Montassier
- MiHAR lab, Nantes University, 44000, Nantes, France.,Department of Emergency Medicine, CHU Nantes, Nantes, France
| | - Ghislaine Le Garcasson
- MiHAR lab, Nantes University, 44000, Nantes, France.,Department of Emergency Medicine, CHU Nantes, Nantes, France
| | | | | | - Didier Lepelletier
- Bacteriology and Infection Control Department, CHU Nantes, 44000, Nantes, France
| | - Jocelyne Caillon
- Bacteriology and Infection Control Department, CHU Nantes, 44000, Nantes, France
| | - Patrice Le Pape
- Parasitology-Mycology Department, Institute of Biology CHU Nantes, Nantes, France
| | | | - Arnaud Bourreille
- Gastroenterology Department, Institute of Digestive Diseases (Institut des Maladies de l'Appareil Digestif - IMAD), CHU Nantes and Nantes University, Nantes, France.,Clinical Investigation Centre CIC1413 team IMAD, CHU Nantes and Inserm, Nantes, France
| |
Collapse
|
26
|
Stahl JP, Bru JP, Gehanno JF, Herrmann JL, Castan B, Deffontaines G, Sotto A, Lepelletier D, Tattevin P, Godefroy N, Haddad E, Mailles A, Lavigne JP. Guidelines for the management of accidental exposure to Brucella in a country with no case of brucellosis in ruminant animals. Med Mal Infect 2020; 50:480-485. [PMID: 32442670 DOI: 10.1016/j.medmal.2020.05.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2020] [Accepted: 05/13/2020] [Indexed: 11/16/2022]
Affiliation(s)
- J P Stahl
- Infectiologie, CHU Grenoble-Alpes, 38043 Grenoble, France.
| | - J P Bru
- Infectiologie, centre hospitalier Annecy-Genevois, Annecy, France.
| | - J F Gehanno
- Médecine du travail, CHU de Rouen, Rouen, France.
| | | | - B Castan
- Infectiologie, centre hospitalier Périgueux, Périgueux, France.
| | - G Deffontaines
- Médecine du travail, mutualité sociale agricole, France.
| | - A Sotto
- Infectiologie, CHU de Nîmes, Nîmes, France; Centre national de référence Brucella, microbiologie, CHU de Nîmes, Nîmes, France.
| | | | - P Tattevin
- Maladies infectieuses et réanimation médicale, hôpital Pontchaillou, CHU de Rennes, Rennes, France.
| | - N Godefroy
- Infectiologie, CHU Pitié-Salpêtrière, Paris, France.
| | - E Haddad
- Maladies infectieuses et réanimation médicale, hôpital Pontchaillou, CHU de Rennes, Rennes, France.
| | - A Mailles
- Direction des maladies infectieuses, santé publique France, Saint-Maurice, France.
| | - J P Lavigne
- Centre national de référence Brucella, microbiologie, CHU de Nîmes, Nîmes, France.
| |
Collapse
|
27
|
Aho Glélé LS, Ortega-Deballon P, Guilloteau A, Keita-Perse O, Astruc K, Lepelletier D. Cluster-randomized crossover trial of chlorhexidine-alcohol versus iodine-alcohol for prevention of surgical-site infection (SKINFECT trial). BJS Open 2020; 4:731-733. [PMID: 32352222 PMCID: PMC7397361 DOI: 10.1002/bjs5.50285] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/13/2019] [Accepted: 02/27/2020] [Indexed: 12/04/2022] Open
Affiliation(s)
- L S Aho Glélé
- Epidemiology and Infection Control Department, 21000, Dijon, France
| | - P Ortega-Deballon
- Digestive Surgery Department, Dijon University Hospital, 14 Rue Paul Gaffarel, 21000, Dijon, France
| | - A Guilloteau
- Epidemiology and Infection Control Department, 21000, Dijon, France
| | - O Keita-Perse
- Epidemiology and Infection Control Department, Monaco Hospital, Monaco
| | - K Astruc
- Epidemiology and Infection Control Department, 21000, Dijon, France
| | - D Lepelletier
- Epidemiology and Infection Control Department, Nantes University Hospital, Nantes, France
| |
Collapse
|
28
|
Lepelletier D, Grandbastien B, Romano-Bertrand S, Aho S, Chidiac C, Géhanno JF, Chauvin F. What face mask for what use in the context of COVID-19 pandemic? The French guidelines. J Hosp Infect 2020; 105:S0195-6701(20)30211-5. [PMID: 32348833 PMCID: PMC7194956 DOI: 10.1016/j.jhin.2020.04.036] [Citation(s) in RCA: 68] [Impact Index Per Article: 17.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/06/2020] [Accepted: 04/23/2020] [Indexed: 11/18/2022]
Abstract
In the context of the COVID-19 pandemic, wearing a face mask has become usual and ubiquitous, in both hospitals and community. However, the general public is consuming surgical or filtering face piece (FFP) masks irrespective of their specificity, leading to global supply shortage for the most exposed persons, which are healthcare workers. This underlines the urgent need to clarify the indications of the different categories of mask, in order to rationalize their use. The study herein specifies the French position for the rational use of respiratory protective equipment for healthcare workers.
Collapse
Affiliation(s)
- Didier Lepelletier
- French Society for Hospital Hygiene, France; Bacteriology and Hospital Hygiene Department, Nantes University Hospital, Nantes, FR-44000; High Council for Public Health, French Ministry of Health.
| | - Bruno Grandbastien
- French Society for Hospital Hygiene, France; Infection Prevention and Control Team, Preventive medicine Department, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, CH-1011
| | - Sara Romano-Bertrand
- French Society for Hospital Hygiene, France; HydroSciences Montpellier, IRD, CNRS, Montpellier University, Montpellier, France; Hospital, Hygiene and Infection Control Team, University Hospital of Montpellier, Montpellier, FR-34000
| | - Serge Aho
- French Society for Hospital Hygiene, France; Epidemiology and Hospital Hygiene Department, Dijon University Hospital, Dijon, FR-21079
| | - Christian Chidiac
- High Council for Public Health, French Ministry of Health; Infectious and Tropical Diseases Department, Lyon University Hospital Hospices Civils de Lyon, Lyon FR-69000
| | - Jean-François Géhanno
- High Council for Public Health, French Ministry of Health; Department of Occupational Medicine, Rouen University Hospital, Rouen, FR-76000
| | - Franck Chauvin
- High Council for Public Health, French Ministry of Health; Public Health Department, St-Etienne University Hospital, St-Etienne, FR-42000
| |
Collapse
|
29
|
Aho Glélé LS, Guilloteau A, Astruc K, Carre Y, Chaize P, Keita-Perse O, Lurton Y, Lepelletier D. ''Methods for microbial needleless connector decontamination: A systematic review and meta-analysis" - Interpret results with caution. Am J Infect Control 2019; 47:1520-1521. [PMID: 31431291 DOI: 10.1016/j.ajic.2019.06.030] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2019] [Revised: 06/18/2019] [Accepted: 06/18/2019] [Indexed: 11/15/2022]
Affiliation(s)
- Ludwig Serge Aho Glélé
- Department of Epidemiology and Infection Control, Dijon University Hospital, Dijon Cedex, France.
| | - Adrien Guilloteau
- Department of Epidemiology and Infection Control, Dijon University Hospital, Dijon Cedex, France
| | - Karine Astruc
- Department of Epidemiology and Infection Control, Dijon University Hospital, Dijon Cedex, France
| | - Yolene Carre
- Department of Infection Control, Bordeaux University Hospital, Bordeaux Cedex, France
| | - Pascal Chaize
- Department of Infection Control, Montpellier University Hospital, Montpellier Cedex, France
| | - Olivia Keita-Perse
- Department of Infection Control, Princess Grace Hospital, Monaco, Monaco
| | - Yves Lurton
- Department of Clinical Pharmacy, Rennes University Hospital, Rennes Cedex, France
| | - Didier Lepelletier
- Department of Infection Control, Nantes University Hospital, Nantes Cedex, France
| |
Collapse
|
30
|
Boisson M, Corbi P, Kerforne T, Camilleri L, Debauchez M, Demondion P, Eljezi V, Flecher E, Lepelletier D, Leprince P, Nesseler N, Nizou JY, Roussel JC, Rozec B, Ruckly S, Lucet JC, Timsit JF, Mimoz O. Multicentre, open-label, randomised, controlled clinical trial comparing 2% chlorhexidine-70% isopropanol and 5% povidone iodine-69% ethanol for skin antisepsis in reducing surgical-site infection after cardiac surgery: the CLEAN 2 study protocol. BMJ Open 2019; 9:e026929. [PMID: 31213447 PMCID: PMC6596966 DOI: 10.1136/bmjopen-2018-026929] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/26/2018] [Revised: 02/14/2019] [Accepted: 04/12/2019] [Indexed: 01/23/2023] Open
Abstract
INTRODUCTION Surgical-site infection (SSI) is the second most frequent cause of healthcare-associated infection worldwide and is associated with increased morbidity, mortality and healthcare costs. Cardiac surgery is clean surgery with low incidence of SSI, ranging from 2% to 5%, but with potentially severe consequences.Perioperative skin antisepsis with an alcohol-based antiseptic solution is recommended to prevent SSI, but the superiority of chlorhexidine (CHG)-alcohol over povidone iodine (PVI)-alcohol, the two most common alcohol-based antiseptic solutions used worldwide, is controversial. We aim to evaluate whether 2% CHG-70% isopropanol is more effective than 5% PVI-69% ethanol in reducing the incidence of reoperation after cardiac surgery. METHODS AND ANALYSIS The CLEAN 2 study is a multicentre, open-label, randomised, controlled clinical trial of 4100 patients undergoing cardiac surgery. Patients will be randomised in 1:1 ratio to receive either 2% CHG-70% isopropanol or 5% PVI-69% ethanol for perioperative skin preparation. The primary endpoint is the proportion of patients undergoing any re-sternotomy between day 0 and day 90 after initial surgery and/or any reoperation on saphenous vein/radial artery surgical site between day 0 and day 30 after initial surgery. Data will be analysed on the intention-to-treat principle. ETHICS AND DISSEMINATION This protocol has been approved by an independent ethics committee and will be carried out according to the principles of the Declaration of Helsinki and the Good Clinical Practice guidelines. The results of this study will be disseminated through presentation at scientific conferences and publication in peer-reviewed journals. TRIAL REGISTRATION NUMBER EudraCT 2017-005169-33 and NCT03560193.
Collapse
Affiliation(s)
- Matthieu Boisson
- Anaesthesia and Intensive Care Unit, Centre Hospitalier Universitaire de Poitiers, Poitiers, France
- INSERM U1070, Universite de Poitiers UFR Medecine et Pharmacie, Poitiers, France
| | - Pierre Corbi
- Cardiothoracic Surgery Unit, Centre Hospitalier Universitaire de Poitiers, Poitiers, France
| | - Thomas Kerforne
- Anaesthesia and Intensive Care Unit, Centre Hospitalier Universitaire de Poitiers, Poitiers, France
| | - Lionel Camilleri
- Cardiothoracic Surgery Unit, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
| | - Mathieu Debauchez
- Cardiothoracic Surgery Unit, Institut Mutualiste Montsouris, Paris, France
| | - Pierre Demondion
- Cardiothoracic Surgery Unit, Hopitaux Universitaires Pitie Salpetriere-Charles Foix, Paris, France
| | - Vedat Eljezi
- Anaesthesia and Intensive Care Unit, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont-Ferrand, France
| | - Erwan Flecher
- Cardiothoracic Surgery Unit, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | - Didier Lepelletier
- Infection Control Unit, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - Pascal Leprince
- Cardiothoracic Surgery Unit, Hopitaux Universitaires Pitie Salpetriere-Charles Foix, Paris, France
| | - Nicolas Nesseler
- Anaesthesia and Intensive Care Unit, Centre Hospitalier Universitaire de Rennes, Rennes, France
| | | | | | - Bertrand Rozec
- Anesthesia and Intensive Care Unit, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - Stéphane Ruckly
- INSERM UMR 1137, Universite Paris Diderot UFR de Medecine Site Xavier-Bichat, Paris, France
| | - Jean-Christophe Lucet
- Infection Control Unit, Hopital Bichat - Claude-Bernard, Paris, France
- Iame, INSERM, Paris, France
| | - Jean-François Timsit
- INSERM UMR 1137, Universite Paris Diderot UFR de Medecine Site Xavier-Bichat, Paris, France
- Medical and Infectious Diseases Intensive Care Unit, Hopital Bichat - Claude-Bernard, Paris, France
| | - Olivier Mimoz
- INSERM U1070, Universite de Poitiers UFR Medecine et Pharmacie, Poitiers, France
- Emergency Department and Prehospital Care, Centre Hospitalier Universitaire de Poitiers, Poitiers, France
| |
Collapse
|
31
|
Birgand G, Haudebourg T, Grammatico-Guillon L, Ferrand L, Moret L, Gouin F, Mauduit N, Leux C, Le Manach Y, Lepelletier D, Tavernier E, Lucet JC, Giraudeau B. Improvement in staff behavior during surgical procedures to prevent post-operative complications (ARIBO 2): study protocol for a cluster randomised trial. Trials 2019; 20:275. [PMID: 31109343 PMCID: PMC6528209 DOI: 10.1186/s13063-019-3370-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2018] [Accepted: 04/16/2019] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Inappropriate staff behaviour during surgical procedures may disrupt the surgical performance and compromise patient safety. We developed an innovative monitoring and feedback system combined with an adaptive approach to optimise staff behaviour intraoperatively and prevent post-operative complications (POC) in orthopaedic surgery. METHODS/DESIGN This protocol describes a parallel-group, cluster randomised, controlled trial with orthopaedic centre as the unit of randomisation. The intervention period will last 6 months and will be based on the monitoring of two surrogates of staff behaviour: the frequency of doors opening and the level of noise. Both will be collected from incision to wound closure, using wireless sensors and sonometers, and recorded and analysed on a dedicated platform (Livepulse®). Staff from centres randomised to the intervention arm will be informed in real time on their own data through an interactive dashboard available in each operating room (OR), and a posteriori for hip and knee replacement POC. Aggregated data from all centres will also be displayed for benchmarking. A lean method will be applied in each centre by a local multidisciplinary team to analyse baseline situations, determine the target condition, analyse the root cause(s), and take countermeasures. The education and awareness of participants on the impact of their behaviour on patient safety will assist the quality improvement process. The control centres will be blinded to monitoring data and quality improvement approaches. The primary outcome will be any POC occurring during the 30 days post operation. We will evaluate this outcome using local and national routinely collected data from hospital discharge and disease databases. Thirty orthopaedic centres will be randomised for a total of 9945 hip and knee replacement surgical procedures. DISCUSSION The field of human factors and behaviour in the OR seems to offer potential room for improvement. An intervention providing goal-setting, monitoring, feedback and action planning may reduce the traffic flow and interruptions/distractions of the surgical team during procedures, preventing subsequent POCs. The results of this trial will provide important data on the impact of OR staff behaviour on patient safety, and promote best practice during surgical procedures. TRIAL REGISTRATION ClinicalTrials.gov, NCT03158181 .
Collapse
Affiliation(s)
- Gabriel Birgand
- CPias Pays de la Loire, Nantes University Hospital, CHU - Le Tourville, 5, rue du Pr Yves Boquien, 44093, Nantes, cedex, France. .,Health Protection Research Unit, Imperial College London, London, UK.
| | - Thomas Haudebourg
- CPias Pays de la Loire, Nantes University Hospital, CHU - Le Tourville, 5, rue du Pr Yves Boquien, 44093, Nantes, cedex, France
| | - Leslie Grammatico-Guillon
- Service de Santé Publique, Unité Régionale d'épidémiologie Hospitalière, CHU, Université de Tours, Tours, France
| | - Léa Ferrand
- Direction de la Recherche Clinique, Nantes University Hospital, Nantes, France
| | - Leila Moret
- Service de Santé Publique, Nantes University Hospital, Nantes, France
| | - François Gouin
- Service de Chirurgie Orthopédique, Nantes University Hospital, Nantes, France
| | - Nicolas Mauduit
- Service D'information Médicale, Nantes University Hospital, Nantes, France
| | - Christophe Leux
- Service D'information Médicale, Nantes University Hospital, Nantes, France
| | - Yannick Le Manach
- Perioperative Medicine and Surgical Research Unit, Population Health Research Institute, David Braley Cardiac, Vascular and Stroke Research Institute, 237 Barton St E, Hamilton, ON, L8L 2X2, Canada
| | | | - Elsa Tavernier
- INSERM CIC 1415, CHRU de Tours, Tours, France.,Université de Tours, Université de Nantes, INSERM SPHERE U1246, Tours, France
| | - Jean-Christophe Lucet
- Unité d'hygiène et de lutte Contre L'infection Nosocomiale (UHLIN), AP-HP, Paris, France
| | - Bruno Giraudeau
- INSERM CIC 1415, CHRU de Tours, Tours, France.,Université de Tours, Université de Nantes, INSERM SPHERE U1246, Tours, France
| |
Collapse
|
32
|
Leclère B, Buckeridge DL, Lepelletier D. Evaluation of a web-based tool for labelling potential hospital outbreaks: a mixed methods study. J Hosp Infect 2019; 103:210-216. [PMID: 31096015 DOI: 10.1016/j.jhin.2019.05.004] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2019] [Revised: 05/05/2019] [Accepted: 05/07/2019] [Indexed: 11/16/2022]
Abstract
BACKGROUND Labelling outbreaks in surveillance data is necessary to train advanced analytical methods for outbreak detection, but there is a lack of software tools dedicated to this task. AIM To evaluate the usability of a web-based tool by infection control practitioners for labelling potential outbreaks. METHODS A mixed methods design was used to evaluate how 25 experts from France and Canada interacted with a web-based application to identify potential outbreaks. Each expert used the application to retrospectively review 11-12 1-year incidence time series from 23 different types of micro-organism. The interactions between the users and the application were recorded and analysed using mixed effect models. The users' comments were analysed via qualitative methods. FINDINGS From the 240 reviews completed, 439 potential outbreaks were labelled, approximately half with a high probability. Significant heterogeneity was observed between users regarding their answers and behaviours (evaluation time, usage of the different options). A significant learning effect was also observed for the experts' interactions with the tool, but this did not seem to impact their answers. The content analysis of the comments highlighted the difficulty of early outbreak identification for practitioners, but also the potential utility of web applications such as that evaluated for routine surveillance. CONCLUSION The interactive web application was both usable and useful for infection control practitioners. Its implementation in routine practice could help professionals to identify potential outbreaks while creating data to train automated detection algorithms.
Collapse
Affiliation(s)
- B Leclère
- Department of Medical Evaluation and Epidemiology, Nantes University Hospital, Nantes, France; MiHAR Laboratory, University of Nantes, Nantes, France; Department of Epidemiology and Biostatistics, McGill University, Montreal, Québec, Canada.
| | - D L Buckeridge
- Department of Epidemiology and Biostatistics, McGill University, Montreal, Québec, Canada
| | - D Lepelletier
- MiHAR Laboratory, University of Nantes, Nantes, France; Department of Bacteriology and Infection Control, Nantes University Hospital, Nantes, France
| |
Collapse
|
33
|
Pivot D, Hoch G, Astruc K, Lepelletier D, Lefebvre A, Lucet JC, Beaussier M, Philippe HJ, Vons C, Triboulet JP, Grandbastien B, Aho Glélé L. A systematic review of surgical site infections following day surgery: a frequentist and a Bayesian meta-analysis of prevalence. J Hosp Infect 2019; 101:196-209. [DOI: 10.1016/j.jhin.2018.07.035] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2018] [Accepted: 07/24/2018] [Indexed: 01/19/2023]
|
34
|
Munir MT, Pailhories H, Eveillard M, Aviat F, Lepelletier D, Belloncle C, Federighi M. Antimicrobial Characteristics of Untreated Wood: Towards a Hygienic Environment. Health (London) 2019. [DOI: 10.4236/health.2019.112014] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
35
|
N'Guyen TTH, Bourigault C, Guillet V, Buttes ACGD, Montassier E, Batard E, Birgand G, Lepelletier D. Association between excreta management and incidence of extended-spectrum β-lactamase-producing Enterobacteriaceae: role of healthcare workers' knowledge and practices. J Hosp Infect 2018; 102:31-36. [PMID: 30557588 DOI: 10.1016/j.jhin.2018.12.006] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2018] [Accepted: 12/10/2018] [Indexed: 11/17/2022]
Abstract
BACKGROUND The spread of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-PE) in healthcare environments has become a major public health threat in recent years. AIM To assess how healthcare workers (HCWs) manage excreta and the possible association with the incidence of ESBL-PE. METHODS Eight hundred HCWs and 74 nurse-supervisors were questioned through two self-report questionnaires in order to assess their knowledge and practices, and to determine the equipment utilized for excreta management in 74 healthcare departments. Performance on equipment utilized, knowledge and practices were scored as good (score of 1), intermediate (score of 2) or poor (score of 3) on the basis of pre-established thresholds. Linear regression was performed to evaluate the association between HCWs' knowledge/practices and the incidence of ESBL-PE. FINDINGS Six hundred and eighty-eight HCWs (86%) and all nurse-supervisors participated in the survey. The proportions of respondents scoring 1, 2 and 3 were: 14.8%, 71.6% and 17.6% for equipment; 30.1%, 40.6 % and 29.3% for knowledge; and 2.0%, 71.9% and 26.1% for practices, respectively. The single regression mathematic model highlighted that poor practices (score of 3) among HCWs was significantly associated with increased incidence of ESBL-PE (P = 0.002). CONCLUSIONS A positive correlation was found between HCWs' practices for managing excreta and the incidence of ESBL-PE, especially in surgical units. There is an urgent need for development of public health efforts to enhance knowledge and practices of HCWs to better control the spread of multi-drug-resistant bacteria, and these should be integrated within infection control programmes.
Collapse
Affiliation(s)
| | - C Bourigault
- MiHAR Lab, University of Nantes, Nantes, France; Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - V Guillet
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - A-C Guille des Buttes
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - E Montassier
- MiHAR Lab, University of Nantes, Nantes, France; Emergency Department, Nantes University Hospital, Nantes, France
| | - E Batard
- MiHAR Lab, University of Nantes, Nantes, France; Emergency Department, Nantes University Hospital, Nantes, France
| | - G Birgand
- MiHAR Lab, University of Nantes, Nantes, France; Regional Infection Control Centre, Pays de la Loire, Nantes, France
| | - D Lepelletier
- MiHAR Lab, University of Nantes, Nantes, France; Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France.
| |
Collapse
|
36
|
Egrot C, Dinh A, Amarenco G, Bernard L, Birgand G, Bruyère F, Chartier-Kastler E, Cosson M, Deffieux X, Denys P, Etienne M, Fatton B, Fritel X, Gamé X, Lawrence C, Lenormand L, Lepelletier D, Lucet JC, Marit Ducamp E, Pulcini C, Robain G, Senneville E, de Sèze M, Sotto A, Zahar JR, Caron F, Hermieu JF. [Antibiotic prophylaxis in urodynamics: Clinical practice guidelines using a formal consensus method]. Prog Urol 2018; 28:943-952. [PMID: 30501940 DOI: 10.1016/j.purol.2018.10.001] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 10/08/2018] [Accepted: 10/11/2018] [Indexed: 10/27/2022]
Abstract
OBJECTIVE The aim of this work was to issue clinical practice guidelines on antibiotic prophylaxis in urodynamics (urodynamic studies, UDS). MATERIALS AND METHODS Clinical practice guidelines were provided using a formal consensus method. Guidelines proposals were drew up by a multidisciplinary experts group (pilot group = steering group), then rated by a panel of 12 experts (rating group) using a formal consensus method, and then peer reviewed by a reviewing/reading group of experts (different from the rating group). RESULTS Urine (bacterial) culture with antimicrobial susceptibility testing is recommended for all patients before UDS (strong agreement). In patients with no neurologic disease, the risk factors for tract urinary infection (UTI) after UDS are age > 70 years, recurrent UTI, and post-void residual volume > 100ml. In patients with neurologic disease, the risk factors for UTI after UDS are recurrent UTI, vesicoureteral reflux, and intermicturition pressure > 40cmH2O. If the urine culture is negative before UDS and there is no risk factor for UTI, antibiotic prophylaxis is not recommended (Strong agreement). If the urine culture is negative before UDS, but there are one or more risk factors for UTI, antibiotic prophylaxis is optional. If antibiotic prophylaxis is initiated, a single oral dose (3g) of fosfomycin-tromethamine two hours before UDS is recommended (Strong agreement). If there is bacterial colonization on UCB before UDS, antibiotic therapy is optional (Undecided). If prescribed, it should be adapted to the antimicrobial susceptibility of the identified bacterium or bacteria, started the day before and stopped after UDS (except for fosfomycin-tromethamine: a single dose the day before UDS is necessary and sufficient) (Strong agreement). In the event of UTI before UDS, the UTI should be treated and UDS postponed (Strong agreement). The proposed recommendations should not be changed for patients with a hip or knee replacement (Strong agreement). No antibiotic prophylaxis of bacterial endocarditis is necessary, including in high-risk patients with valvular heart disease (Strong agreement). CONCLUSION These new guidelines should help to harmonize clinical practice and limit exposure to antibiotics. LEVEL OF EVIDENCE 4.
Collapse
Affiliation(s)
- C Egrot
- Service d'urologie, université Paris-7, hôpital Bichat Claude-Bernard, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France.
| | - A Dinh
- Unité de maladies infectieuses, UVSQ, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France
| | - G Amarenco
- GRC 01, groupe de recherche clinique en neuro-urologie (GREEN), Sorbonne université, hôpital Tenon, AP-HP, 75020 Paris, France
| | - L Bernard
- Service de médecine interne et maladies infectieuses, centre hospitalier régional Bretonneau, 37000 Tours, France
| | - G Birgand
- Centre de prévention des infections associées aux soins, CHU de Nantes, 5, rue du Pr-Boquien, 44000 Nantes, France
| | - F Bruyère
- Service d'urologie, centre hospitalier régional universitaire de Tours, 37000 Tours, France
| | - E Chartier-Kastler
- Médecine Sorbonne Université, hôpital universitaire de la Pitié-Salpêtrière, 75013 Paris, France
| | - M Cosson
- Laboratoire BioTIM, école centrale de Lille, université de Lille, CHU de Lille, 59000 Lille, France
| | - X Deffieux
- Service de gynécologie obstétrique, université Paris-Sud, hôpital Antoine-Béclère, groupe hospitalier Sud, AP-HP, 92140 Clamart, France
| | - P Denys
- Service de neuro-urologie, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France
| | - M Etienne
- Service de maladies infectieuses et tropicales, hôpital Charles-Nicolle, CHU de Rouen, 76000 Rouen, France
| | - B Fatton
- Unité d'urogynécologie, groupe hospitalier Carémeau, CHU de Nîmes, 30029 Nîmes, France
| | - X Fritel
- Service de gynécologie-obstétrique, CHU de Poitiers, 86000 Poitiers, France
| | - X Gamé
- Département d'urologie, transplantation rénale et andrologie, CHU Rangueil, TSA 50032, 31059 Toulouse, France
| | - C Lawrence
- Service microbiologie et hygiène, hôpital Raymond-Poincaré, AP-HP, 92380 Garches, France
| | - L Lenormand
- Service d'urologie, centre fédératif de pelvipérinéologie, CHU de Nantes, place A.-Ricordeau, 44093 Nantes cedex 01, France
| | - D Lepelletier
- Service bactériologie et hygiène hospitalière, CHU de Nantes, 44093 Nantes cedex 01, France
| | - J-C Lucet
- Service de bactériologie, hygiène, virologie, parasitologie, hôpital Bichat-Claude-Bernard, AP-HP, Paris, France
| | - E Marit Ducamp
- Service de médecine physique et réadaptation, urodynamique, clinique Saint-Augustin, 33200 Bordeaux, France
| | - C Pulcini
- Infectious Diseases Department, université de Lorraine, APEMAC, CHRU de Nancy, 54000 Nancy, France
| | - G Robain
- Service de rééducation neurologique, hôpital Rothschild, AP-HP, 75012 Paris, France
| | - E Senneville
- Service universitaire des maladies infectieuses et du voyageur, centre hospitalier Gustave-Dron, CHRU de Lille, 59200 Tourcoing, France
| | - M de Sèze
- Service de médecine physique et réadaptation, urodynamique, clinique Saint-Augustin, 33200 Bordeaux, France
| | - A Sotto
- Service des maladies infectieuses et tropicales, CHU de Nîmes, place du Professeur-Robert-Debré, 30029 Nîmes cedex, France
| | - J-R Zahar
- Département de microbiologie, hôpital Avicenne, AP-HP, groupe hospitalier Paris-Seine-Saint-Denis, 93000 Bobigny, France; Unité de recherche Inserm 1137, IAME, université Paris-13, 93000 Bobigny, France
| | - F Caron
- Service des maladies infectieuses, groupe de recherche sur l'adaptation microbienne (EA2656), université de Rouen, CHU de Rouen, 76000 Rouen, France
| | - J-F Hermieu
- Service d'urologie, université Paris-7, hôpital Bichat Claude-Bernard, AP-HP, 46, rue Henri-Huchard, 75018 Paris, France
| |
Collapse
|
37
|
Bourigault C, Le Gallou F, Bodet N, Musquer N, Juvin ME, Corvec S, Ferronnière N, Wiesel S, Gournay J, Birgand G, Le Rhun M, Lepelletier D. Duodenoscopy: an amplifier of cross-transmission during a carbapenemase-producing Enterobacteriaceae outbreak in a gastroenterology pathway. J Hosp Infect 2018; 99:422-426. [DOI: 10.1016/j.jhin.2018.04.015] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2018] [Accepted: 04/13/2018] [Indexed: 12/01/2022]
|
38
|
Guilley-Lerondeau B, Bourigault C, Guille des Buttes A, Lepelletier D. Évaluation de l’impact psychologique des précautions complémentaires chez les patients hospitalisés dans un centre hospitalier universitaire. Med Mal Infect 2018. [DOI: 10.1016/j.medmal.2018.04.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
39
|
Le Hir F, Longuenesse C, Lepelletier D, Bernier C. Dermites des mains chez les soignants de réanimation : causes et impact sur l’hygiène des mains. Ann Dermatol Venereol 2017. [DOI: 10.1016/j.annder.2017.09.385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
40
|
Zahar JR, Jolivet S, Adam H, Dananché C, Lizon J, Alfandari S, Boulestreau H, Baghdadi N, Bay JO, Bénéteau AM, Bougnoux ME, Brenier-Pinchart MP, Dalle JH, Fournier S, Fuzibet JG, Kauffmann-Lacroix C, Le Guinche I, Lepelletier D, Loukili N, Lory A, Morvan M, Oumedaly R, Ribaud P, Rohrlich P, Vanhems P, Aho S, Vanjak D, Gangneux JP. [French recommendations on control measures to reduce the infectious risk in immunocompromised patients]. J Mycol Med 2017; 27:449-456. [PMID: 29132793 DOI: 10.1016/j.mycmed.2017.10.004] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/12/2017] [Revised: 10/14/2017] [Accepted: 10/15/2017] [Indexed: 11/27/2022]
Abstract
The increase use of immunosuppressive treatments in patients with solid cancer and/or inflammatory diseases requires revisiting our practices for the prevention of infectious risk in the care setting. A review of the literature by a multidisciplinary working group at the beginning of 2014 wished to answer the following 4 questions to improve healthcare immunocompromised patients: (I) How can we define immunocompromised patients with high, intermediate and low infectious risk, (II) which air treatment should be recommended for this specific population? (III) What additional precautions should be recommended for immunocompromised patients at risk for infection? (IV) Which global environmental control should be recommended? Based on data from the literature and using the GRADE method, we propose 15 recommendations that could help to reduce the risk of infection in these exposed populations.
Collapse
Affiliation(s)
- J-R Zahar
- Département de microbiologie clinique, unité de contrôle et de prévention du risque infectieux, IAME, UMR 1137, université Paris 13, Sorbonne Paris Cité, groupe hospitalier Paris-Seine-Saint-Denis, CHU Avicenne, AP-HP, 125, rue de Stalingrad, 93000 Bobigny, France.
| | - S Jolivet
- Unité d'hygiène et de lutte contre les infections nosocomiales, GH Bichat-Claude-Bernard, 75877 Paris, France
| | - H Adam
- Service d'épidémiologie et d'hygiène hospitalière, hôpital d'enfants, CHU, 14, rue Paul-Gaffarel, BP 77908, 21079 Dijon cedex, France
| | - C Dananché
- Service hygiène, épidémiologie et prévention, centre international de recherche en infectiologie, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, laboratoire des pathogènes émergents, fondation mérieux, Hospices Civils de Lyon, Lyon, 69003 France
| | - J Lizon
- Pôle laboratoires, équipe opérationnelle d'hygiène hospitalière, CHRU de Nancy, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France; Département d'hygiène, des risques environnementaux et associés aux soins, faculté de médecine, université de Lorraine, 9, avenue de la Forêt-de-Haye, CS 50184, 54505 Vandœuvre-Lès-Nancy cedex, France
| | - S Alfandari
- Service de réanimation et maladies infectieuses, centre hospitalier Dron, 59200 Tourcoing, France
| | - H Boulestreau
- Service d'hygiène hospitalière, CHU de Bordeaux, Bordeaux, France
| | - N Baghdadi
- Unité Véronese, CHRU de Lille, UHSA, CS 70001, 59037 Lille cedex, France
| | - J-O Bay
- Service de thérapie cellulaire et d'hématologie clinique adulte, CHU de Clermont-Ferrand, 1, place Lucie-et-Raymond-Aubrac, 63003 Clermont-Ferrand cedex 01, France
| | - A-M Bénéteau
- Département en hygiène, institut Curie, 35, rue Dailly, 92210 Saint-Cloud, France
| | - M-E Bougnoux
- Unité de parasitologie-mycologie, service de microbiologie clinique, hôpital Necker-Enfants-Malades, AP-HP, Paris, France; Unité de biologie et pathogénicité fongiques, Institut Pasteur, université Paris-Descartes, 75019 Paris, France
| | - M-P Brenier-Pinchart
- Inserm U1209, CNRS UMR5309, laboratoire de parasitologie-mycologie, institut de biologie et pathologie, France 2 institute for advanced biosciences (IAB), team host-pathogen interactions and immunity to infection, université Grenoble-Alpes, CHU de Grenoble-Alpes, 38700 Grenoble, France
| | - J-H Dalle
- Service d'hémato-immunologie, université Paris-Diderot, hôpital Robert-Debré, Assistance publique-Hôpitaux de Paris, 75019 Paris, France
| | - S Fournier
- Équipe opérationnelle d'hygiène, direction de l'organisation médicale, AP-HP, 75184 Paris, France
| | - J-G Fuzibet
- Service de médecine interne, hôpital de l'Archet 1, CHU de Nice, 06200 Nice, France
| | - C Kauffmann-Lacroix
- Laboratoire de parasitologie mycologie, CHU de Poitiers, bâtiment UBM, 2, rue de la Milétrie, CS 90577, 86021 Poitiers cedex, France
| | - I Le Guinche
- Équipe opérationnelle d'hygiène, CHU Necker-Enfants-Malades, 75015 Paris, France
| | - D Lepelletier
- Bactériologie-hygiène hospitalière, centre hospitalier universitaire de Nantes, 44093 Nantes cedex 01, France
| | - N Loukili
- Unité de lutte contre les infections nosocomiales, SGRIVI, CHRU de Lille, 59000 Lille, France
| | - A Lory
- ARLIN PACA, hôpital de Ste-Marguerite, AP-HM, 13009 Marseille, France
| | - M Morvan
- Équipe opérationnelle d'hygiène, CHRU de Montpellier, 34295 Montpellier, France
| | - R Oumedaly
- Institut d'hématologie de Basse Normandie (IHBN), CHU de Caen, 14000 Caen, France
| | - P Ribaud
- Département d'hématologie, CHU Saint-Louis, AP-HP, 75010 Paris, France
| | - P Rohrlich
- Inserm U1065, service d'hémato-oncologie pédiatrique, université Côte-d'Azur, centre hospitalier universitaire de Nice, 06204 Nice, France
| | - P Vanhems
- Service hygiène, épidémiologie et prévention, centre international de recherche en infectiologie, Inserm U1111, CNRS UMR5308, ENS de Lyon, UCBL1, laboratoire des pathogènes émergents, fondation mérieux, Hospices Civils de Lyon, Lyon, 69003 France
| | - S Aho
- Service d'épidémiologie et d'hygiène hospitalière, hôpital d'enfants, CHU, 14, rue Paul-Gaffarel, BP 77908, 21079 Dijon cedex, France
| | - D Vanjak
- Équipe opérationnelle d'hygiène, institut Curie, 26, rue d'ULM, 75005 Paris, France
| | - J-P Gangneux
- Service de parasitologie-mycologie, centre hospitalier universitaire de Rennes, 2, rue Henri-le-Guilloux, 35033 Rennes cedex 09, France
| |
Collapse
|
41
|
Batard E, Vibet MA, Thibaut S, Corvec S, Pivette J, Lepelletier D, Caillon J, Montassier E. Tetracycline use in the community may promote decreased susceptibility to quinolones in Escherichia coli isolates. Eur J Clin Microbiol Infect Dis 2017; 37:271-276. [PMID: 29076047 DOI: 10.1007/s10096-017-3127-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2017] [Accepted: 10/17/2017] [Indexed: 10/18/2022]
Abstract
We previously found that the hospital use of tetracyclines is associated with quinolone resistance in hospital isolates of Enterobacteriaceae. Tetracyclines are heavily used in the community. Our aim was to assess whether their use in the community favors quinolone resistance in community isolates of Escherichia coli. Monthly data of community antibiotics use and E. coli quinolone resistance in a 1.3 million inhabitant French area were obtained from 2009 to 2014, and were analyzed with autoregressive integrated moving average (ARIMA) models. Quinolone use decreased from 10.1% of the total antibiotic use in 2009 to 9.3% in 2014 (trend, - 0.016; p-value < 0.0001), while tetracycline use increased from 16.5% in 2009 to 17.1% in 2014 (trend, 0.016; p < 0.0001). The mean (95% confidence interval) monthly proportions of isolates that were non-susceptible to nalidixic acid and ciprofloxacin were 14.8% (14.2%-15.5%) and 9.5% (8.8%-10.1%), respectively, with no significant temporal trend. After adjusting on quinolone use, tetracycline use in the preceding month was significantly associated with nalidixic acid non-susceptibility (estimate [SD], 0.01 [0.007]; p-value, 0.04), but not with ciprofloxacin non-susceptibility (estimate [SD], 0.01 [0.009]; p-value, 0.23). Tetracycline use in the community may promote quinolone non-susceptibility in E. coli. Decreasing both tetracycline and quinolone use may be necessary to fight against the worldwide growth of quinolone resistance.
Collapse
Affiliation(s)
- E Batard
- Microbiotas Hosts Antibiotics bacterial Resistances (MiHAR) Lab, Institut de Recherche en Santé 2 (IRS2), Université de Nantes, 22 Boulevard Benoni-Goullin, 44200, Nantes, France. .,Emergency Department, Centre Hospitalier Universitaire de Nantes, Nantes, France.
| | - M-A Vibet
- Laboratoire de Mathématiques Jean Leray, Université de Nantes, Nantes, France
| | - S Thibaut
- Medqual, Centre Ressource en Antibiologie, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - S Corvec
- Bacteriology and Infection Control, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - J Pivette
- Medical Department, French Health Insurance Scheme, Nantes, France
| | - D Lepelletier
- Microbiotas Hosts Antibiotics bacterial Resistances (MiHAR) Lab, Institut de Recherche en Santé 2 (IRS2), Université de Nantes, 22 Boulevard Benoni-Goullin, 44200, Nantes, France.,Bacteriology and Infection Control, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - J Caillon
- Medqual, Centre Ressource en Antibiologie, Centre Hospitalier Universitaire de Nantes, Nantes, France.,Bacteriology and Infection Control, Centre Hospitalier Universitaire de Nantes, Nantes, France
| | - E Montassier
- Microbiotas Hosts Antibiotics bacterial Resistances (MiHAR) Lab, Institut de Recherche en Santé 2 (IRS2), Université de Nantes, 22 Boulevard Benoni-Goullin, 44200, Nantes, France.,Emergency Department, Centre Hospitalier Universitaire de Nantes, Nantes, France
| |
Collapse
|
42
|
Longuenesse C, Lepelletier D, Dessomme B, Le Hir F, Bernier C. Hand dermatitis: hand hygiene consequences among healthcare workers. Contact Dermatitis 2017; 77:330-331. [DOI: 10.1111/cod.12825] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2017] [Revised: 03/28/2017] [Accepted: 03/31/2017] [Indexed: 11/26/2022]
Affiliation(s)
- Claire Longuenesse
- Occupational Health Department; Nantes University Hospital; 44000 Nantes France
| | - Didier Lepelletier
- Bacteriology and Infection Control Department; Nantes University Hospital; 44000 Nantes France
| | - Brigitte Dessomme
- Medical Evaluation and Epidemiology Department; Nantes University Hospital; 44000 Nantes France
| | - Fabien Le Hir
- Occupational Health Department; Nantes University Hospital; 44000 Nantes France
| | - Claire Bernier
- Dermatology Department; Nantes University Hospital; 44000 Nantes France
| |
Collapse
|
43
|
Birgand G, Hayatgheib N, Bémer P, Guilloteau V, Legeay C, Perron S, Chapelet G, Corvec S, Bourigault C, Batard E, Lepelletier D. Multi-drug-resistant Enterobacteriacae carriage in highly exposed nursing homes: prevalence in western France. J Hosp Infect 2017; 97:258-259. [PMID: 28774743 DOI: 10.1016/j.jhin.2017.07.032] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2017] [Accepted: 07/26/2017] [Indexed: 11/19/2022]
Affiliation(s)
- G Birgand
- Regional Centre for Infection Prevention and Control, Region of Pays de la Loire, France; Health Protection Research Unit, Healthcare Associated Infection and Antimicrobial Resistance, Imperial College London, London, UK
| | - N Hayatgheib
- University of Nantes, MiHAR Lab, UFR Medicine, Nantes, France; ONIRIS National Veterinary School (Man-imal One Health Master 2 degree), Nantes, France
| | - P Bémer
- University of Nantes, MiHAR Lab, UFR Medicine, Nantes, France; Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - V Guilloteau
- Infection Control Unit, Chalonnes Hospital Centre, Chalonnes, France
| | - C Legeay
- Infection Control Unit, Angers University Hospital, Angers, France
| | - S Perron
- Infection Control Unit, Saumur Hospital Centre, Saumur, France
| | - G Chapelet
- University of Nantes, MiHAR Lab, UFR Medicine, Nantes, France; Gerontologic Department, Nantes University Hospital, Nantes, France
| | - S Corvec
- Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - C Bourigault
- University of Nantes, MiHAR Lab, UFR Medicine, Nantes, France; Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France
| | - E Batard
- University of Nantes, MiHAR Lab, UFR Medicine, Nantes, France; Emergency Department, Nantes University Hospital, Nantes, France
| | - D Lepelletier
- University of Nantes, MiHAR Lab, UFR Medicine, Nantes, France; ONIRIS National Veterinary School (Man-imal One Health Master 2 degree), Nantes, France; Bacteriology and Infection Control Department, Nantes University Hospital, Nantes, France.
| |
Collapse
|
44
|
Eveillard M, Pouliquen H, Ruvoen N, Couvreur S, Krempf M, Magras C, Lepelletier D. Antibiotic exposure and bacterial resistance in human and veterinary medicine: a problem-based learning topic for Master's students. FEMS Microbiol Lett 2017; 364:fnx015. [PMID: 28119372 DOI: 10.1093/femsle/fnx015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2016] [Accepted: 01/19/2017] [Indexed: 11/14/2022] Open
Abstract
This report describes a problem-based learning activity concerning antibiotic exposure and bacterial resistance in human and veterinary medicine. In addition, learning outcomes and satisfaction of students were recorded by the supervisors of the activity. The students all participated actively in the group work and considered that the small size of the group facilitated interpersonal communication. They believed that working in an interdisciplinary group helped them learn better than if they were following specific courses. They also reported that their mid-term meeting with one of the supervisors was a catalyst for the initiation of a real work group. Concerning the evaluation of the activity itself, the supervisors considered that the group provided a relevant analysis of the issue. These characteristics should encourage teachers to test this method of learning certain aspects of microbiology and infectious diseases with their students.
Collapse
Affiliation(s)
- Matthieu Eveillard
- L'UBL, MAN-IMAL IDEFI ANR 11-0003, 44307 Nantes, France.,L'UBL, UFR Santé, Université d'Angers, 40 Rue de Rennes, F-49035 Angers, France
| | - Hervé Pouliquen
- L'UBL, MAN-IMAL IDEFI ANR 11-0003, 44307 Nantes, France.,ONIRIS, Nantes-Atlantic National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet, BP 40706, F-44307 Nantes Cedex 03, France
| | - Nathalie Ruvoen
- L'UBL, MAN-IMAL IDEFI ANR 11-0003, 44307 Nantes, France.,ONIRIS, Nantes-Atlantic National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet, BP 40706, F-44307 Nantes Cedex 03, France
| | - Sébastien Couvreur
- L'UBL, MAN-IMAL IDEFI ANR 11-0003, 44307 Nantes, France.,ESA Group, 55 Rue Rabelais, BP 30748, F-49007 Angers Cedex 01, France
| | - Michel Krempf
- L'UBL, MAN-IMAL IDEFI ANR 11-0003, 44307 Nantes, France.,L'UBL, UFR Santé, Université de Nantes, 1 Quai de Tourville, 44000 Nantes, France
| | - Catherine Magras
- L'UBL, MAN-IMAL IDEFI ANR 11-0003, 44307 Nantes, France.,ONIRIS, Nantes-Atlantic National College of Veterinary Medicine, Food Science and Engineering, Route de Gachet, BP 40706, F-44307 Nantes Cedex 03, France
| | - Didier Lepelletier
- L'UBL, MAN-IMAL IDEFI ANR 11-0003, 44307 Nantes, France.,L'UBL, UFR Santé, Université de Nantes, 1 Quai de Tourville, 44000 Nantes, France
| |
Collapse
|
45
|
Leclère B, Buckeridge DL, Boëlle PY, Astagneau P, Lepelletier D. Automated detection of hospital outbreaks: A systematic review of methods. PLoS One 2017; 12:e0176438. [PMID: 28441422 PMCID: PMC5404859 DOI: 10.1371/journal.pone.0176438] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2016] [Accepted: 04/10/2017] [Indexed: 12/23/2022] Open
Abstract
OBJECTIVES Several automated algorithms for epidemiological surveillance in hospitals have been proposed. However, the usefulness of these methods to detect nosocomial outbreaks remains unclear. The goal of this review was to describe outbreak detection algorithms that have been tested within hospitals, consider how they were evaluated, and synthesize their results. METHODS We developed a search query using keywords associated with hospital outbreak detection and searched the MEDLINE database. To ensure the highest sensitivity, no limitations were initially imposed on publication languages and dates, although we subsequently excluded studies published before 2000. Every study that described a method to detect outbreaks within hospitals was included, without any exclusion based on study design. Additional studies were identified through citations in retrieved studies. RESULTS Twenty-nine studies were included. The detection algorithms were grouped into 5 categories: simple thresholds (n = 6), statistical process control (n = 12), scan statistics (n = 6), traditional statistical models (n = 6), and data mining methods (n = 4). The evaluation of the algorithms was often solely descriptive (n = 15), but more complex epidemiological criteria were also investigated (n = 10). The performance measures varied widely between studies: e.g., the sensitivity of an algorithm in a real world setting could vary between 17 and 100%. CONCLUSION Even if outbreak detection algorithms are useful complementary tools for traditional surveillance, the heterogeneity in results among published studies does not support quantitative synthesis of their performance. A standardized framework should be followed when evaluating outbreak detection methods to allow comparison of algorithms across studies and synthesis of results.
Collapse
Affiliation(s)
- Brice Leclère
- Department of Medical Evaluation and Epidemiology, Nantes University Hospital, Nantes, France
- MiHAR laboratory, Nantes University, Nantes, France
| | - David L. Buckeridge
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Canada
| | - Pierre-Yves Boëlle
- UMR S 1136, Pierre Louis Institute of Epidemiology and Public Health, Pierre and Marie Curie University, Paris, France
| | - Pascal Astagneau
- Department of Public Health, Pierre and Marie Curie University, Paris, France
- Centre de Coordination de la Lutte contre les Infections Nosocomiales Paris-Nord, Hôpital Broussais, Paris, France
| | - Didier Lepelletier
- MiHAR laboratory, Nantes University, Nantes, France
- Department of Microbiology and Infection Control, Nantes University Hospital, Nantes, France
| |
Collapse
|
46
|
Aubin GG, Lavigne JP, Foucher Y, Dellière S, Lepelletier D, Gouin F, Corvec S. Tropism and virulence of Cutibacterium (formerly Propionibacterium) acnes involved in implant-associated infection. Anaerobe 2017; 47:73-78. [PMID: 28454760 DOI: 10.1016/j.anaerobe.2017.04.009] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2017] [Revised: 03/14/2017] [Accepted: 04/20/2017] [Indexed: 11/28/2022]
Abstract
The recognition of the pathogenicity of Cutibacterium acnes in implant-associated infection is not always obvious. In this paper, we aimed to distinguish pathogenic and non-pathogenic C. acnes isolates. To reach this goal, we investigated the clonal complex (CC) of a large collection of C. acnes clinical isolates through Multi-Locus Sequence Typing (MLST), we established a Caenorhabditis elegans model to assess C. acnes virulence and we investigated the presence of virulence factors in our collection. Ours results showed that CC36 and CC53 C. acnes isolates were more frequently observed in prosthetic joint infections (PJI) than CC18 and CC28 C. acnes isolates (p = 0.021). The C. elegans model developed here showed two distinct virulence groups of C. acnes (p < 0.05). These groups were not correlated to CC or clinical origin. Whole genome sequencing allowed us to identify a putative gene linked to low virulent strains. In conclusion, MLST remains a good method to screen pathogenic C. acnes isolates according to their clinical context but mechanisms of C. acnes virulence need to be assess thought transcriptomic analysis to investigate regulatory process.
Collapse
Affiliation(s)
- Guillaume Ghislain Aubin
- EA3826, Laboratory of Clinical and Experimental Therapeutics of Infections, IRS 2, Nantes University, Nantes, France; Bacteriology and Hygiene Unit, CHU Nantes, France
| | - Jean-Philippe Lavigne
- INSERM, U1047, University of Montpellier, Nîmes, France; Department of Microbiology, Caremeau University Hospital, Nîmes, France
| | - Yohan Foucher
- EA4275 SPHERE-Biostatistics, Clinical Research and Pharmaco-Epidemiology, IRS 2, 22 Bd Bénoni-Goullin, University of Nantes, Nantes, France
| | | | - Didier Lepelletier
- Bacteriology and Hygiene Unit, CHU Nantes, France; MiHAR Lab, IRS 2, 22 Bd Bénoni-Goullin, University of Nantes, Nantes, France
| | - François Gouin
- Clinique Chirurgicale orthopédique et traumatique, CHU Nantes, Nantes, France
| | - Stéphane Corvec
- Bacteriology and Hygiene Unit, CHU Nantes, France; CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.
| |
Collapse
|
47
|
Aubin GG, Deschanvres C, Boutoille D, Abgueguen P, Corvec S, Caillon J, Lepelletier D, Moal F, Navas D. Daptomycin use: where is the truth? Future Microbiol 2016; 12:9-12. [PMID: 27936929 DOI: 10.2217/fmb-2016-0142] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
- Guillaume Ghislain Aubin
- Department of Bacteriology & Infection control, Nantes University Hospital, Nantes, France.,EA3826, Laboratory of Clinical & Experimental Therapeutics of Infections, IRS2, 22 Bd Bénoni-Goullin, Nantes, France
| | - Colin Deschanvres
- Infectious Diseases Department, Nantes University Hospital, Nantes, France
| | - David Boutoille
- EA3826, Laboratory of Clinical & Experimental Therapeutics of Infections, IRS2, 22 Bd Bénoni-Goullin, Nantes, France.,Infectious Diseases Department, Nantes University Hospital, Nantes, France
| | - Pierre Abgueguen
- Infectious Diseases Department, Angers University Hospital, Angers, France
| | - Stéphane Corvec
- Department of Bacteriology & Infection control, Nantes University Hospital, Nantes, France
| | - Jocelyne Caillon
- Department of Bacteriology & Infection control, Nantes University Hospital, Nantes, France.,EA3826, Laboratory of Clinical & Experimental Therapeutics of Infections, IRS2, 22 Bd Bénoni-Goullin, Nantes, France
| | - Didier Lepelletier
- Department of Bacteriology & Infection control, Nantes University Hospital, Nantes, France.,Microbiotas, Hosts, Antibiotics & Bacterial Resistances Lab, IRS2, 22 Bd Bénoni-Goullin, Nantes, France
| | - Frédéric Moal
- Pharmacy Department, Angers University Hospital, Angers, France
| | - Dominique Navas
- EA3826, Laboratory of Clinical & Experimental Therapeutics of Infections, IRS2, 22 Bd Bénoni-Goullin, Nantes, France.,Pharmacy Department, Nantes University Hospital, Nantes, France
| |
Collapse
|
48
|
Bernier C, Lepelletier D, Moret L, Lehir F, Dupas D, Longuenesse C. Conséquences des dermites des mains chez les soignants. Ann Dermatol Venereol 2016. [DOI: 10.1016/j.annder.2016.09.373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
49
|
Deschanvres C, Boutoille D, Abgueguen P, Corvec S, Huon J, Lepelletier D, Caillon J, Moal F, Navas D, Aubin G. BU-23 - Focus sur les disparités d’utilisation de la daptomycine entre CHU. Med Mal Infect 2016. [DOI: 10.1016/s0399-077x(16)30347-x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
50
|
Penit A, Bemer P, Besson J, Cazet L, Bourigault C, Juvin ME, Fix MH, Bruley des Varannes S, Boutoille D, Batard E, Lepelletier D. Community-acquired Clostridium difficile infections. Med Mal Infect 2016; 46:131-9. [PMID: 27039068 DOI: 10.1016/j.medmal.2016.01.007] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2015] [Revised: 11/25/2015] [Accepted: 01/19/2016] [Indexed: 11/18/2022]
Abstract
OBJECTIVE To describe the management and treatment of community-acquired C. difficile infections (CDI) and to evaluate family physicians' (FP) knowledge and practice. PATIENTS AND METHODS Observational study from December 2013 to June 2014. All community-acquired CDI case patients diagnosed in the community or at the University Hospital of Nantes were prospectively included. A questionnaire was mailed to 150 FPs of the area of Nantes. RESULTS A total of 27 community-acquired CDI case patients were included (incidence: 7.7 case patients/100,000 inhabitants). Mean age was higher among case patients diagnosed at hospital (69years) compared with those diagnosed in the community (44years). Fifteen patients were treated at home (55%) and 22 received a first-line treatment with metronidazole. Only one patient did not receive any prior antibiotic treatment. Amoxicillin-clavulanic acid was mainly prescribed (68%) for respiratory and ENT infections (40%). Twenty-three patients were cured on Day 7 and three had complications (two deaths). Thirty-one of 47 FPs reported to have already managed CDI patients. Twenty-two FPs reported to usually treat patients with uncomplicated CDI at home, 21 to refer patients to a specialist, and three to hospital. Forty-one FPs reported to prescribe a CD toxin test only after recent antibiotic exposure and 30 when patients are at risk of CDI. CONCLUSION The incidence and impact of community-acquired CDIs may be underestimated and the unjustified use of antibiotics may promote their emergence. FPs are not used to treat CDIs as more than 50% prefer referring patients to hospital or to a specialist.
Collapse
Affiliation(s)
- A Penit
- Pôle de gérontologie clinique, CHU de Nantes, 44093 Nantes, France
| | - P Bemer
- Service de bactériologie-hygiène hospitalière, CHU de Nantes, 44093 Nantes, France
| | - J Besson
- Laboratoire d'analyses médicales Biolance, 44000 Nantes, France
| | - L Cazet
- Service de bactériologie-hygiène hospitalière, CHU de Nantes, 44093 Nantes, France
| | - C Bourigault
- Service de bactériologie-hygiène hospitalière, CHU de Nantes, 44093 Nantes, France
| | - M-E Juvin
- Service de bactériologie-hygiène hospitalière, CHU de Nantes, 44093 Nantes, France
| | - M-H Fix
- Pôle de gérontologie clinique, CHU de Nantes, 44093 Nantes, France
| | | | - D Boutoille
- Service des maladies infectieuses et tropicales, CHU de Nantes, 44093 Nantes, France; UPRES EA 3826, UFR médecine, université de Nantes, 44035 Nantes, France
| | - E Batard
- Service d'accueil des urgences, CHU de Nantes, 44093 Nantes, France; UPRES EA 3826, UFR médecine, université de Nantes, 44035 Nantes, France
| | - D Lepelletier
- Service de bactériologie-hygiène hospitalière, CHU de Nantes, 44093 Nantes, France; UPRES EA 3826, UFR médecine, université de Nantes, 44035 Nantes, France.
| |
Collapse
|